<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://lipcancer.eu/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/2.8.6" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.2" -->
<!-- generated-on="September 9, 2010 5:33 am" -->
<!-- Debug: Total comment count: 310 -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://lipcancer.eu/</loc>
		<lastmod>2010-09-09T11:26:20+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings -->
<!-- Debug: Priority report of postID 674: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/comparative-evaluation-of-nbuvb-phototherapy-and-puva-photochemotherapy-in-chronic-plaque-psoriasis</loc>
		<lastmod>2010-09-09T11:26:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 673: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/quality-of-life-and-voice-after-radiotherapy-speech-therapy-repercussions</loc>
		<lastmod>2010-09-08T20:26:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 672: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/desmoglein-3-and-keratin-10-expressions-are-reduced-by-chronic-exposure-to-cigarette-smoke-in-human-keratinised-oral-mucosa-explants</loc>
		<lastmod>2010-09-08T05:23:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 671: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/survival-and-quality-of-life-of-patients-with-oral-and-oropharyngeal-cancer-at-1-year-follow-up-of-tumor-resection</loc>
		<lastmod>2010-09-07T14:23:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 670: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/effects-of-vandetanib-on-adenoma-formation-in-a-dextran-sodium-sulphate-enhanced-apcmin-mouse-model</loc>
		<lastmod>2010-09-06T23:23:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 669: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/efforts-by-dentist-couple-toward-dental-health-of-family</loc>
		<lastmod>2010-09-06T23:13:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 668: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bisphosphonates-may-double-cancer-risk</loc>
		<lastmod>2010-09-06T08:23:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 667: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/how-to-prevent-wrinkles-with-time</loc>
		<lastmod>2010-09-06T08:14:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 666: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/osteoporosis-drug-linked-to-cancer</loc>
		<lastmod>2010-09-05T17:18:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 665: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ingredients-in-your-lipstick-is-your-health-at-risk</loc>
		<lastmod>2010-09-05T17:10:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 664: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/about-face-oral-bisphosphonates-linked-to-esophageal-cancer</loc>
		<lastmod>2010-09-05T02:16:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 663: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-escalation-of-public-smoking-the-vestiges-from-ash-to-ash</loc>
		<lastmod>2010-09-05T02:09:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 662: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/osteoporosis-medication-doubles-cancer-risk</loc>
		<lastmod>2010-09-04T11:18:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 661: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/avail-the-preeminent-cosmetic-makeover</loc>
		<lastmod>2010-09-04T11:08:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 660: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/long-term-use-of-oral-bisphosphonates-may-double-risk-of-esophageal-cancer-study-finds</loc>
		<lastmod>2010-09-03T20:15:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 659: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/penta-o-galloyl-beta-d-glucose-induces-g1-arrest-and-dna-replicative-s-phase-arrest-independently-of-cyclin-dependent-kinase-inhibitor-1a-cyclin-dependent-kinase-inhibitor-1b-and-p53-in-human-breast</loc>
		<lastmod>2010-09-03T05:13:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 658: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/tips-on-choosing-the-best-sunscreen</loc>
		<lastmod>2010-09-03T05:05:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 657: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/treatment-of-primary-hepatocellular-carcinoma</loc>
		<lastmod>2010-09-02T14:13:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 656: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/join-the-new-religion-for-hair-ghd-hair-straighteners</loc>
		<lastmod>2010-09-02T14:04:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 655: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/you-jump-to-the-most-nightmarish-conclusion</loc>
		<lastmod>2010-09-01T23:10:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 654: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/have-a-look-at-the-best-cosmetic-makeover</loc>
		<lastmod>2010-09-01T23:05:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 653: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/nct01110291-induction-of-cyp3a-activity-and-lowered-exposure-to-docetaxel-in-patients-with-primary-breast-cancer</loc>
		<lastmod>2010-09-01T08:09:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 652: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/luminescence-of-radium-and-maryas-death</loc>
		<lastmod>2010-09-01T08:05:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 651: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/circadian-expression-of-clock-and-tumor-suppressor-genes-in-human-oral-mucosa</loc>
		<lastmod>2010-08-31T17:11:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 650: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/does-broccoli-aid-gut-problems</loc>
		<lastmod>2010-08-31T02:06:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 649: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/complete-information-on-costello-syndrome</loc>
		<lastmod>2010-08-31T02:03:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 648: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/phase-ii-study-of-biweekly-docetaxel-and-s-1-combination-chemotherapy-as-first-line-treatment-for-advanced-gastric-cancer</loc>
		<lastmod>2010-08-30T11:06:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 647: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cdhsdh-type-gastrointestinal-surgery-in-esophagus-surgery-stapling</loc>
		<lastmod>2010-08-30T11:00:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 646: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/prevention-oral-bisphosphonate-use-may-protect-women-from-breast-cancer</loc>
		<lastmod>2010-08-29T20:03:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 645: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/nutrition-therapy-plays-a-role-in-childhood-cancer-care</loc>
		<lastmod>2010-08-29T20:03:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 644: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/moisturizer-during-summer</loc>
		<lastmod>2010-08-29T19:57:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 643: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/younger-adults-with-oral-cavity-squamous-cell-cancer-have-a-significantly-higher-5-year-survival-rate-than-do-older-adults-ina%c2%a0the-united-states-controlling-for-patient-and-disease-specific-cha</loc>
		<lastmod>2010-08-29T05:06:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 642: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/premalignant-nature-of-oral-and-vulval-lichen-planus-facts-and-controversies</loc>
		<lastmod>2010-08-28T14:02:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 641: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/original-article-increased-expression-of-peroxiredoxin-6-and-cyclophilin-a-in-squamous-cell-carcinoma-of-the-tongue</loc>
		<lastmod>2010-08-27T23:00:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 640: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/evaluation-and-management-of-pericardial-effusion-in-patients-with-neoplastic-disease</loc>
		<lastmod>2010-08-27T08:01:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 639: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-chelation-should-it-be-used-with-young-children</loc>
		<lastmod>2010-08-26T16:57:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 638: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-bisphosphonates-not-linked-to-oesophageal-cancer-risk</loc>
		<lastmod>2010-08-26T01:57:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 637: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/complete-information-on-actinic-cheilitis-with-treatment-and-prevention</loc>
		<lastmod>2010-08-26T01:49:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 636: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/musculoskeletal-adverse-events-associated-with-adjuvant-aromatase-inhibitors</loc>
		<lastmod>2010-08-25T10:56:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 635: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/facial-and-its-many-types</loc>
		<lastmod>2010-08-25T10:47:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 634: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/head-and-neck-cancer</loc>
		<lastmod>2010-08-24T19:54:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 633: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/intraoperative-portable-abdominal-radiograph-for-tumor-localization-a-simple-and-accurate-method-for-laparoscopic-gastrectomy</loc>
		<lastmod>2010-08-24T04:52:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 632: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oriental-diagnosis-find-out-the-state-of-your-health-before-illness-sets-in</loc>
		<lastmod>2010-08-24T04:47:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 631: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/exogenous-sex-hormone-use-and-risk-of-meningioma-a-population-based-casea%c2%80%c2%93control-study-in-finland</loc>
		<lastmod>2010-08-23T13:50:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 630: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/i-conquered-ms-and-my-sons-epilepsy</loc>
		<lastmod>2010-08-23T13:43:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 629: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/relationship-between-plasma-concentrations-of-morphine-and-its-metabolites-and-pain-in-cancer-patients</loc>
		<lastmod>2010-08-22T22:52:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 628: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/how-to-take-care-of-your-mouth-during-chemotherapy-dental-instructions</loc>
		<lastmod>2010-08-22T22:44:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 627: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/gender-specific-quality-of-life-in-patients-with-oral-squamous-cell-carcinomas</loc>
		<lastmod>2010-08-22T07:50:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 626: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-saliva-based-hpv-tests-establish-cancer-risk-and-guide-patient-management</loc>
		<lastmod>2010-08-22T07:50:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 625: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oil-free-moisturizer-for-your-skin</loc>
		<lastmod>2010-08-22T07:50:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 624: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/risk-factors-for-non-invasive-lesions-of-the-fallopian-tube-in-brca-mutation-carriers</loc>
		<lastmod>2010-08-21T16:48:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 623: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cerebral-palsy</loc>
		<lastmod>2010-08-21T16:48:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 622: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/stryker-navigation-system-protocol-for-craniofacial-reconstruction-planning</loc>
		<lastmod>2010-08-21T01:53:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 621: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/gene-expression-of-oncogenes-antimicrobial-peptides-and-cytokines-in-the-development-of-oral-leukoplakia</loc>
		<lastmod>2010-08-21T01:53:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 620: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/hey-females-know-yourself-via-nakshtras</loc>
		<lastmod>2010-08-21T01:42:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 619: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/demographics-and-efficacy-of-head-and-neck-cancer-screening</loc>
		<lastmod>2010-08-20T10:46:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 618: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/entanglements-of-mind-what-you-are-doing-as-a-couple-outside-the-bedroom</loc>
		<lastmod>2010-08-20T10:36:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 617: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/pyridoxine-is-not-effective-to-prevent-hand-foot-syndrome-associated-with-capecitabine-therapy-results-of-a-randomized-double-blind-placebo-controlled-study-treatment-related-complications</loc>
		<lastmod>2010-08-19T19:45:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 616: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/primary-care-perceptions-of-otolaryngology</loc>
		<lastmod>2010-08-19T04:43:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 615: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/life-outside-the-bedroom-couples-as-entanglements-of-emergent-morphogenic-fields</loc>
		<lastmod>2010-08-19T04:34:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 614: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/esophageal-pathology-in-patients-after-treatment-for-head-and-neck-cancer</loc>
		<lastmod>2010-08-18T13:41:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 613: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/destiny-myths-the-fateful-day</loc>
		<lastmod>2010-08-18T13:33:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 612: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/scientists-discover-how-polyphenols-in-green-tea-may-protect-health-of-diabetics</loc>
		<lastmod>2010-08-17T22:39:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 611: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/destiny-the-joint-venture-of-fate-with-your-soul-and-will</loc>
		<lastmod>2010-08-17T22:31:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 610: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/managing-the-adverse-effects-of-radiation-therapy</loc>
		<lastmod>2010-08-17T07:38:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 609: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-candidiasis</loc>
		<lastmod>2010-08-17T07:33:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 608: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/eruptive-keratoacanthoma-and-squamous-cell-carcinoma-complicating-imiquimod-therapy-response-to-oral-acitretin</loc>
		<lastmod>2010-08-16T16:38:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 607: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/specially-for-females-know-yourself-via-nakshtras</loc>
		<lastmod>2010-08-16T16:38:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 606: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-phase-ii-study-of-s-1-and-oxaliplatin-sox-combination-chemotherapy-as-a-first-line-therapy-for-patients-with-advanced-gastric-cancer</loc>
		<lastmod>2010-08-16T01:50:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 605: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/help-i-have-found-a-lump-on-my-dog</loc>
		<lastmod>2010-08-16T01:50:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 604: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/phase-ii-trial-of-sunitinib-in-patients-with-metastatic-non-clear-cell-renal-cell-carcinoma</loc>
		<lastmod>2010-08-15T10:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 603: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/jesus-christ-superman-part-five</loc>
		<lastmod>2010-08-15T10:40:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 602: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bisphosphonate-use-does-not-raise-cancer-risk</loc>
		<lastmod>2010-08-14T19:49:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 601: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-contraceptives-increase-breast-cancer-risk-in-african-american-women</loc>
		<lastmod>2010-08-14T19:49:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 600: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/dietary-folic-acids-why-do-we-need-them-more</loc>
		<lastmod>2010-08-14T19:25:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 599: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/use-of-certain-drugs-to-treat-osteoporosis-not-associated-with-increased-risk-of-esophageal-or-gastric-cancer</loc>
		<lastmod>2010-08-14T04:32:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 598: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/how-smoking-affects-everyone</loc>
		<lastmod>2010-08-14T04:23:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 597: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/trial-under-way-for-oral-cancer-test</loc>
		<lastmod>2010-08-13T13:30:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 596: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-bisphosphonates-not-linked-to-esophageal-or-gastric-cancer</loc>
		<lastmod>2010-08-12T22:28:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 595: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/babas-heart</loc>
		<lastmod>2010-08-12T22:23:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 594: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/exposure-to-oral-bisphosphonates-and-risk-of-esophageal-cancer-original-contribution</loc>
		<lastmod>2010-08-12T07:29:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 593: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/teeth-and-chemotherapy</loc>
		<lastmod>2010-08-12T07:20:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 592: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bisphosphonates-not-linked-to-esophageal-cancer-says-study</loc>
		<lastmod>2010-08-11T16:32:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 591: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/10-steps-to-good-digestion-and-better-health</loc>
		<lastmod>2010-08-11T16:32:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 590: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/involvement-of-salivary-glands-in-regulating-the-human-nitrate-and-nitrite-levels</loc>
		<lastmod>2010-08-11T01:31:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 589: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-tests-are-the-most-helpful-as-screening-tests-for-inflammatory-bowel-disease</loc>
		<lastmod>2010-08-10T10:26:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 588: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/uses-of-the-element-named-after-the-devil</loc>
		<lastmod>2010-08-10T10:26:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 587: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-dentist-test-to-detect-oral-cancer-will-save-lives</loc>
		<lastmod>2010-08-09T19:22:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 586: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/developing-a-suntan-ultra-voilet-rays</loc>
		<lastmod>2010-08-09T19:15:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 585: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/stress-gets-under-our-skin</loc>
		<lastmod>2010-08-09T04:20:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 584: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancer-detection-by-new-fluorescent-probe</loc>
		<lastmod>2010-08-08T13:21:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 583: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/exalted-planets-results-when-aspected-by-exalted-planets-and-deblitated-planets</loc>
		<lastmod>2010-08-08T13:11:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 582: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/interventions-for-treating-oral-mucositis-for-patients-with-cancer-receiving-treatment</loc>
		<lastmod>2010-08-07T22:19:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 581: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/elective-radiotherapy-or-neck-dissection-for-ct-staged-t1-2n0-oral-tongue-cancer</loc>
		<lastmod>2010-08-07T07:16:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 580: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/energy-therapy-for-a-more-beautiful-you</loc>
		<lastmod>2010-08-07T07:10:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 579: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/research-shows-oral-and-topical-agents-hold-promise-in-preventing-uv-induced-skin-cancer</loc>
		<lastmod>2010-08-06T16:15:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 578: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/asian-skin-care-advice</loc>
		<lastmod>2010-08-06T16:11:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 577: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-pill-may-increase-breast-cancer-risk</loc>
		<lastmod>2010-08-06T01:16:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 576: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-contraceptive-use-associated-with-increased-risk-of-breast-cancer-in-african-american-women-study-finds</loc>
		<lastmod>2010-08-05T10:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 575: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-sun-in-gemini</loc>
		<lastmod>2010-08-05T10:07:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 574: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/hpv-linked-to-head-neck-cancers</loc>
		<lastmod>2010-08-04T19:12:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 573: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-best-supplements-and-ingredients-for-dog-joint-health</loc>
		<lastmod>2010-08-04T19:09:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 572: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/reflection-and-reaction-molecularly-targeted-therapy-when-to-stop-and-when-to-continue</loc>
		<lastmod>2010-08-04T04:12:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 571: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/an-update-on-targeted-therapy-in-metastatic-renal-cell-carcinoma</loc>
		<lastmod>2010-08-03T13:19:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 570: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/why-should-you-quit-smoking</loc>
		<lastmod>2010-08-03T13:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 569: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/c-reactive-protein-levels-a-prognostic-marker-for-patients-with-head-and-neck-cancer</loc>
		<lastmod>2010-08-02T22:09:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 568: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/epithelial-mesenchymal-transition-in-oral-squamous-cell-carcinoma-triggered-by-transforming-growth-factor-beta1-is-snail-family-dependent-and-correlates-with-matrix-metalloproteinase-2-and-9-expressi</loc>
		<lastmod>2010-08-02T07:11:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 567: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/effects-of-lentinan-alone-and-in-combination-with-fluoropyrimidine-anticancer-agent-on-growth-of-human-oral-squamous-cell-carcinoma-in-vitro-and-in-vivo</loc>
		<lastmod>2010-08-01T16:05:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 566: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lack-of-vitamins-can-be-bad-for-your-health</loc>
		<lastmod>2010-08-01T15:58:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 565: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/effect-of-6-shogaol-on-cytosolic-ca2-levels-and-proliferation-in-human-oral-cancer-cells-oc2</loc>
		<lastmod>2010-08-01T01:03:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 564: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-photoaging</loc>
		<lastmod>2010-08-01T00:58:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 563: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/saving-my-skin-at-the-top-of-the-world</loc>
		<lastmod>2010-07-31T10:02:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 562: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/leukoplakia-a-premalignant-lesion</loc>
		<lastmod>2010-07-31T10:02:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 561: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/african-ancestry-linked-to-triple-negative-breast-cancer</loc>
		<lastmod>2010-07-30T19:05:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 560: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/adipose-tissue-accumulation-of-d-limonene-with-the-consumption-of-a-lemonade-preparation-rich-in-d-limonene-content</loc>
		<lastmod>2010-07-30T04:03:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 559: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/voice-problems-and-voice-care-ent-surgeon-bangalore</loc>
		<lastmod>2010-07-30T03:53:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 558: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/pharmaceutical-drug-contamination-of-waterways-threatens-life-on-our-planet</loc>
		<lastmod>2010-07-29T13:04:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 557: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/healing-with-vit-c</loc>
		<lastmod>2010-07-29T12:55:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 556: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/taiwan-study-finds-oral-cancer-rates-up-280-per-cent-blames-betel</loc>
		<lastmod>2010-07-28T21:59:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 555: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/3-reasons-to-stop-smoking-for-good</loc>
		<lastmod>2010-07-28T21:59:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 554: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/multiple-keratocystic-odontogenic-tumors-associated-with-nevoid-basal-cell-carcinoma-syndrome-having-distinct-ptch1-mutations-a-case-report</loc>
		<lastmod>2010-07-28T06:58:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 553: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/zhejiang-province-urgent-investigation-profiteering-medicine-asparagus-pieces</loc>
		<lastmod>2010-07-28T06:51:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 552: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sebaceous-carcinoma-of-the-oral-cavity-a-case-report-and-review-of-the-literature</loc>
		<lastmod>2010-07-27T15:55:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 551: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/summer-skin-care</loc>
		<lastmod>2010-07-27T15:51:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 550: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cinnamon-extract-induces-tumor-cell-death-through-inhibition-of-nfkb-and-ap1</loc>
		<lastmod>2010-07-27T01:37:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 549: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cold-sore-freedom-in-3-days-review-ebook-download</loc>
		<lastmod>2010-07-27T01:37:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 548: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/hospital-school-program-helps-demystify-cancer-for-classmates-of-young-patients</loc>
		<lastmod>2010-07-26T09:53:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 547: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/stimulating-moments-of-happiness</loc>
		<lastmod>2010-07-26T09:47:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 546: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/gene-may-hold-key-to-reducing-spread-of-oral-cancers</loc>
		<lastmod>2010-07-25T18:53:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 545: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/protect-your-children-against-overexposure-to-the-sun</loc>
		<lastmod>2010-07-25T18:48:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 544: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/possible-coffee-perk</loc>
		<lastmod>2010-07-25T03:52:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 543: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/dental-approach-in-the-pediatric-oncology-patient-characteristics-of-the-population-treated-at-the-dentistry-unit-in-a-pediatric-oncology-brazilian-teaching-hospital</loc>
		<lastmod>2010-07-24T12:50:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 542: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/common-skin-disorders-and-their-remedies</loc>
		<lastmod>2010-07-24T12:41:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 541: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/role-of-genes-in-oro-dental-diseases</loc>
		<lastmod>2010-07-23T21:49:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 540: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/immunohistochemical-evaluation-of-mast-cells-and-angiogenesis-in-oral-squamous-cell-carcinoma</loc>
		<lastmod>2010-07-23T21:49:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 539: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/side-effects-of-chemotherapy</loc>
		<lastmod>2010-07-23T21:40:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 538: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/expression-of-a-chemokine-brakcxcl14-in-oral-floor-carcinoma-cells-reduces-the-settlement-rate-of-the-cells-and-suppresses-their-proliferation-in-vivo</loc>
		<lastmod>2010-07-23T06:48:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 537: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/pamper-yourself-have-the-essence-of-being-in-cloud-9</loc>
		<lastmod>2010-07-23T06:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 536: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/antioxidants-help-arteries-stay-healthy-in-people-at-risk-for-heart-disease</loc>
		<lastmod>2010-07-22T15:46:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 535: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/experiences-in-astrology</loc>
		<lastmod>2010-07-22T15:43:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 534: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/seeking-clues-causes-associations-and-improvedsafer-treatment-options-for-infantile-hemangiomas</loc>
		<lastmod>2010-07-22T00:45:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 533: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/face-and-figure-how-and-when-determind-lagna-ascendant-face-reading</loc>
		<lastmod>2010-07-22T00:38:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 532: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bisphosphonates-for-osteoporosis-reduce-risk-for-breast-cancer</loc>
		<lastmod>2010-07-21T09:42:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 531: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/15-anhydro-d-fructose-and-its-derivatives-biosynthesis-preparation-and-potential-medical-applications</loc>
		<lastmod>2010-07-20T18:41:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 530: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/glutamic-acid-decarboxylase-antibody-positive-paraneoplastic-stiff-limb-syndrome-associated-with-carcinoma-of-the-breast</loc>
		<lastmod>2010-07-20T03:39:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 529: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/know-yourself-from-your-own-signs</loc>
		<lastmod>2010-07-20T03:32:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 528: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/pseudomonas-aeruginosa-exotoxin-a-reduces-chemoresistance-of-oral-squamous-carcinoma-cell-via-inhibition-of-heat-shock-proteins-70-hsp70</loc>
		<lastmod>2010-07-19T12:38:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 527: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/taking-care-of-your-teeth-and-mouth</loc>
		<lastmod>2010-07-19T12:33:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 526: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/comparison-between-two-methods-for-human-papilomava%c2%adrus-dna-detection-in-lip-squamous-cell-carcinoma</loc>
		<lastmod>2010-07-18T21:40:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 525: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/effect-of-body-mass-index-on-recurrences-in-tamoxifen-and-anastrozole-treated-women-an-exploratory-analysis-from-the-atac-trial-breast-cancer</loc>
		<lastmod>2010-07-18T06:40:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 524: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/coldsore-quick-treatment-methods</loc>
		<lastmod>2010-07-18T06:35:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 523: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/report-of-a-multicenter-phase-ii-trial-testing-a-combination-of-biweekly-bevacizumab-and-daily-erlotinib-in-patients-with-unresectable-biliary-cancer-a-phase-ii-consortium-study-gastrointestinal-can</loc>
		<lastmod>2010-07-17T15:35:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 522: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-most-important-lipstick-list-youll-ever-read</loc>
		<lastmod>2010-07-17T15:28:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 521: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/aeterna-zentaris-announces-perifosine-has-received-orphan-drug-designation-for-the-treatment-of-neuroblastoma</loc>
		<lastmod>2010-07-17T00:34:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 520: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/smoking-effects-protect-your-lungs-and-your-health</loc>
		<lastmod>2010-07-17T00:25:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 519: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cutaneous-metastasis-of-squamous-cell-carcinoma-of-oral-mucosa-with-a-purpura-like-appearance-with-tumor-thrombosis-in-lymphatic-vessels</loc>
		<lastmod>2010-07-16T09:37:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 518: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/addition-of-sunitinib-to-cetuximab-and-irinotecan-in-patients-with-heavily-pre-treated-advanced-colorectal-cancer</loc>
		<lastmod>2010-07-15T18:30:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 517: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/researchers-study-relationship-of-oral-cancers-and-periodontal-disease</loc>
		<lastmod>2010-07-15T03:28:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 516: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/indoor-tanners-have-higher-risk-of-melanoma</loc>
		<lastmod>2010-07-15T03:23:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 515: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/dental-researchers-discover-human-beta-defensin-3-ignites-in-oral-cancer-growth</loc>
		<lastmod>2010-07-14T12:27:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 514: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/alimta-cisplatin-chemotherapy-for-mesothelioma-patients</loc>
		<lastmod>2010-07-14T12:22:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 513: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/quality-of-sleep-in-head-and-neck-cancer-patients</loc>
		<lastmod>2010-07-13T21:26:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 512: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/monosol-rx-announces-fda-approval-of-zuplenzr-oral-soluble-film-for-treatment-of-nausea-and-vomiting</loc>
		<lastmod>2010-07-13T06:39:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 511: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/pain-dry-mouth-may-play-role-in-sleep-quality-of-head-and-neck-cancer-patients</loc>
		<lastmod>2010-07-12T15:24:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 510: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/how-you-can-start-breast-feeding</loc>
		<lastmod>2010-07-12T15:20:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 509: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/inhibition-of-l-type-amino-acid-transporter-modulates-the-expression-of-cell-cycle-regulatory-factors-in-kb-oral-cancer-cells</loc>
		<lastmod>2010-07-12T00:26:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 508: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/exalted-planets-results-when-aspected-by-exalted-planets-and-debilitated-planets</loc>
		<lastmod>2010-07-12T00:26:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 507: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/orange-botswana-and-botswana-upenn-partnership-pioneer-mobile-phone-telemedicine</loc>
		<lastmod>2010-07-11T09:21:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 506: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/interventions-for-treating-oral-candidiasis-for-patients-with-cancer-receiving-treatment</loc>
		<lastmod>2010-07-10T18:20:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 505: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/natural-winter-skin-care</loc>
		<lastmod>2010-07-10T18:13:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 504: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/posaconazole</loc>
		<lastmod>2010-07-10T03:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 503: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/tobacco-smoking-and-cancer-in-brazil-evidence-and-prospects</loc>
		<lastmod>2010-07-09T12:19:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 502: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sunburn-and-blistering</loc>
		<lastmod>2010-07-09T12:09:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 501: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-increasing-the-dose-of-radiation-by-hdr-brachytherapy-boost-following-pre-operative-chemoradiotherapy-for-advanced-rectal-cancer-improve-surgical-outcomes</loc>
		<lastmod>2010-07-08T21:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 500: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/horizon-scanning-oral-polyadp-ribose-polymerase-inhibitor-olaparib-in-patients-with-brca1-or-brca2-mutations-and-advanced-breast-cancer-or-recurrent-ovarian-cancer</loc>
		<lastmod>2010-07-08T06:25:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 499: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-drug-shows-early-promise</loc>
		<lastmod>2010-07-07T15:14:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 498: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/potential-mesothelioma-treatment-uncovered</loc>
		<lastmod>2010-07-07T15:07:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 497: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/fda-approves-strativa-pharmaceuticals-zuplenza%c2%ae-ondansetron-oral-soluble-film</loc>
		<lastmod>2010-07-07T00:11:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 496: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/thyroidectomy-surgery-in-india-at-affordable-cost-%e2%80%93thyroidectomy-india</loc>
		<lastmod>2010-07-07T00:04:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 495: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/serum-amyloid-p-ameliorates-radiation-induced-oral-mucositis-and-fibrosis</loc>
		<lastmod>2010-07-06T09:13:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 494: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/vitamin-d-and-health-bones-and-beyond</loc>
		<lastmod>2010-07-06T09:09:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 493: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/quantitative-detection-of-4-hydroxyequilenin-dna-adducts-in-mammalian-cells-using-an-immunoassay-with-a-novel-monoclonal-antibody</loc>
		<lastmod>2010-07-05T18:30:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 492: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/raloxifene-stimulated-experimental-breast-cancer-with-the-paradoxical-actions-of-estrogen-to-promote-or-prevent-tumor-growth-a-unifying-concept-in-anti-hormone-resistance</loc>
		<lastmod>2010-07-05T03:10:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 491: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/outcome-of-local-failures-after-oral-cancer-recurrence-vs-second-primary</loc>
		<lastmod>2010-07-04T12:06:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 490: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-most-important-lipstick-list-you%e2%80%99ll-ever-read</loc>
		<lastmod>2010-07-04T12:01:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 489: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/votrient-pazopanib-now-available-for-the-treatment-of-advanced-renal-cell-carcinoma-rcc</loc>
		<lastmod>2010-07-03T21:05:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 488: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/skin-care-myths-and-your-beauty-regime</loc>
		<lastmod>2010-07-03T20:58:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 487: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bitter-melon-extracts-block-breast-cancer</loc>
		<lastmod>2010-07-03T06:05:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 486: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/stop-smoking-%e2%80%93-gain-more-than-to-lose-anything</loc>
		<lastmod>2010-07-03T05:57:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 485: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/famri-funded-research-helps-harness-cancer-killing-viruses</loc>
		<lastmod>2010-07-02T15:05:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 484: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-advantages-of-using-natural-pet-supplements</loc>
		<lastmod>2010-07-02T14:56:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 483: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/keryx-biopharmaceuticals-krx-0401-perifosine-data-selected-for-oral-presentation-at-the-upcoming-12th-world-congress-on-gastrointestinal-cancer</loc>
		<lastmod>2010-07-02T00:01:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 482: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/face-reading-via-nakshatras</loc>
		<lastmod>2010-07-01T23:54:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 481: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-squamous-cell-carcinoma-status-of-tight-junction-claudins-in-the-different-histopathological-patterns-and-relationship-with-clinical-parameters-a-tissue-microarray-based-study-of-136-cases</loc>
		<lastmod>2010-07-01T09:00:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 480: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/beauty-and-the-beast</loc>
		<lastmod>2010-07-01T08:52:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 479: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-incidence-and-survival-in-metro-manila-and-rizal-province-philippines</loc>
		<lastmod>2010-06-30T18:00:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 478: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/10-steps-to-help-you-stay-safe-in-the-sun</loc>
		<lastmod>2010-06-30T17:53:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 477: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-therapeutic-indication-authorised-for-gska%c2%80%c2%99s-tyverb-lapatinib</loc>
		<lastmod>2010-06-30T02:59:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 476: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/rancid-religious-rites</loc>
		<lastmod>2010-06-30T02:50:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 475: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/weight-lifting-in-patients-with-lower-extremity-lymphedema-secondary-to-cancer-a-pilot-and-feasibility-study</loc>
		<lastmod>2010-06-29T12:26:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 474: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/pre-operative-medical-assessment-of-dental-patient</loc>
		<lastmod>2010-06-29T11:48:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 473: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/frequent-dose-interruptions-are-required-for-patients-receiving-oral-kinase-inhibitor-therapy-for-advanced-renal-cell-carcinoma</loc>
		<lastmod>2010-06-28T20:55:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 472: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/health-hazards-of-smoking</loc>
		<lastmod>2010-06-28T20:55:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 471: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/role-of-environmental-factors-in-the-etiology-of-hepatocellular-carcinoma</loc>
		<lastmod>2010-06-28T05:53:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 470: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/tobacco-the-silent-killer</loc>
		<lastmod>2010-06-28T05:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 469: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/jane-goodall-50-years-working-with-chimps-discover-interview</loc>
		<lastmod>2010-06-27T14:52:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 468: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/using-tobacco-videos</loc>
		<lastmod>2010-06-27T14:44:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 467: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/effect-of-the-menstrual-cycle-and-hormonal-contraceptives-on-human-papillomavirus-detection-in-young-unscreened-women</loc>
		<lastmod>2010-06-26T23:52:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 466: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/overall-effects-of-smoking</loc>
		<lastmod>2010-06-26T23:46:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 465: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-therapeutic-indication-authorised-for-gsks-tyverb</loc>
		<lastmod>2010-06-26T08:56:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 464: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/calcitriol-125-dihydroxycholecalciferol-enhances-mast-cell-tumour-chemotherapy-and-receptor-tyrosine-kinase-inhibitor-activity-in-vitro-and-has-single-agent-activity-against-spontaneously-occurring</loc>
		<lastmod>2010-06-25T17:51:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 463: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/tobacco-use-and-the-big-c</loc>
		<lastmod>2010-06-25T17:40:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 462: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/an-exploratory-study-of-sunitinib-plus-paclitaxel-as-first-line-treatment-for-patients-with-advanced-breast-cancer</loc>
		<lastmod>2010-06-25T02:49:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 461: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/survival-in-oral-cavity-minor-salivary-gland-carcinoma</loc>
		<lastmod>2010-06-24T11:46:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 460: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/summer-sun-protection-tips</loc>
		<lastmod>2010-06-24T11:40:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 459: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/discrepancy-of-the-effects-of-zinc-supplementation-on-the-prevention-of-radiotherapy-induced-mucositis-between-patients-with-nasopharyngeal-carcinoma-and-those-with-oral-cancers-subgroup-analysis-of</loc>
		<lastmod>2010-06-23T20:46:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 458: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/treatment-results-of-postoperative-radiotherapy-on-squamous-cell-carcinoma-of-the-oral-cavity-coexistence-of-multiple-minor-risk-factors-results-in-higher-recurrence-rates</loc>
		<lastmod>2010-06-23T05:43:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 457: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/testicle-pain-are-swollen-testicles-scrotum-pain-or-lumps-signs-of-testicular-cancer-or-hernia</loc>
		<lastmod>2010-06-23T05:35:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 456: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-truth-about-recovering-from-a-brain-injury</loc>
		<lastmod>2010-06-22T14:45:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 455: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/prostate-cancer-and-prevention</loc>
		<lastmod>2010-06-22T14:38:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 454: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/surgical-resection-for-oral-tongue-cancer-pulmonary-metastases-institutional-report-thoracic-oncologic</loc>
		<lastmod>2010-06-21T23:41:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 453: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/if-the-symptoms-of-genital-warts-are-not-treated-early-it-could-lead-to-more-serious-conditions-like-cervical-cancer</loc>
		<lastmod>2010-06-21T23:35:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 452: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/four-coffees-a-day-will-keep-mouth-cancer-at-bay</loc>
		<lastmod>2010-06-21T08:45:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 451: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/anxious-times</loc>
		<lastmod>2010-06-20T17:42:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 450: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/plastic-surgery-for-patients-recovering-from-cancer</loc>
		<lastmod>2010-06-20T17:32:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 449: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/eating-experiences-of-children-and-adolescents-with-chemotherapy-related-nausea-and-mucositis</loc>
		<lastmod>2010-06-20T02:43:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 448: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/squamous-cell-carcinoma-in-a-patient-with-oral-lichen-planus-treated-with-topical-application-of-tacrolimus</loc>
		<lastmod>2010-06-19T11:37:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 447: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bladder-cancer-and-smokeless-tobacco</loc>
		<lastmod>2010-06-19T11:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 446: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/dental-extractions-in-patients-receiving-bisphosphonate-therapy</loc>
		<lastmod>2010-06-18T20:35:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 445: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/michael-jacksons-skin-cancer</loc>
		<lastmod>2010-06-18T20:27:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 444: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/high-risk-human-papillomavirus-in-the-oral-cavity-of-women-with-cervical-cancer-and-their-children</loc>
		<lastmod>2010-06-18T05:38:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 443: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/diseases-and-condition-%e2%80%93-skin-cancer-treatments</loc>
		<lastmod>2010-06-18T05:26:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 442: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/apoptosis-induction-of-zbb-006-a-novel-synthetic-diterpenoid-in-the-human-hepatocellular-carcinoma-cell-line-hepg2-in-vitro-and-in-vivo</loc>
		<lastmod>2010-06-17T14:39:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 441: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/diagnostic-approaches-of-oral-diseases-and-screening-for-oral-cancer</loc>
		<lastmod>2010-06-17T14:25:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 440: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/dallass-first-scarless-robotic-surgery-for-throat-cancers-performed</loc>
		<lastmod>2010-06-16T23:34:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 439: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/early-detection-and-prevention-of-oral-cancer</loc>
		<lastmod>2010-06-16T23:28:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 438: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/eribulin-mesylate-significantly-improved-overall-survival-in-patients-with-locally-recurrent-or-metastatic-breast-cancer</loc>
		<lastmod>2010-06-16T08:31:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 437: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/detection-of-centrosome-aberrations-in-disease-unrelated-cells-from-patients-with-tumor-treated-with-tyrosine-kinase-inhibitors</loc>
		<lastmod>2010-06-15T17:27:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 436: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/mouthwash-may-lead-to-oral-cancer</loc>
		<lastmod>2010-06-15T17:26:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 435: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-systematic-review-of-orofacial-pain-in-patients-receiving-cancer-therapy</loc>
		<lastmod>2010-06-14T11:29:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 434: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-systematic-review-of-viral-infections-associated-with-oral-involvement-in-cancer-patients-a-spotlight-on-herpesviridea</loc>
		<lastmod>2010-06-13T20:26:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 433: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/quercetin-abrogates-chemoresistance-in-melanoma-cells-by-modulating-deltanp73</loc>
		<lastmod>2010-06-13T05:26:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 432: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oropharyngeal-cancer-a-real-reason-to-kick-the-habit</loc>
		<lastmod>2010-06-13T05:26:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 431: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/integrative-analysis-of-dna-copy-number-and-gene-expression-in-metastatic-oral-squamous-cell-carcinoma-identifies-genes-associated-with-poor-survival</loc>
		<lastmod>2010-06-12T14:21:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 430: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/%e2%80%98grey%e2%80%99s-anatomy%e2%80%99-star-denies-cancer-story</loc>
		<lastmod>2010-06-12T14:16:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 429: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/glycogen-synthase-kinase-3-beta-can-it-be-a-target-for-oral-cancer</loc>
		<lastmod>2010-06-11T23:20:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 428: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-randomized-double-blind-cross-over-patient-preference-study-of-pazopanib-versus-sunitinib-in-treatment-naive-locally-advanced-or-metastatic-renal-cell-carcinoma</loc>
		<lastmod>2010-06-11T08:18:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 427: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/behind-cancer-and-careers-is-beauty</loc>
		<lastmod>2010-06-11T08:13:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 426: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/prometic-presentations-at-the-european-hematology-associations-annual-meeting-offer-insights-into-pbi-1402s-expanded-indications-in-oncology</loc>
		<lastmod>2010-06-10T17:21:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 425: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/nice-rules-against-nhs-funding-for-tyverb-lapatinib-an-effective-treatment-for-advanced-breast-cancer</loc>
		<lastmod>2010-06-10T02:21:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 424: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/early-detection-helps-fight-cancer-by-medimanage-com</loc>
		<lastmod>2010-06-10T02:21:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 423: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/safety-of-recombinant-human-growth-hormone</loc>
		<lastmod>2010-06-09T11:16:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 422: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/mouth-cancer-detection</loc>
		<lastmod>2010-06-09T11:07:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 421: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/maintenance-treatment-with-oral-lenalidomide-after-stem-cell-transplant-reduces-risk-of-disease-progression-for-multiple-myeloma-patients</loc>
		<lastmod>2010-06-08T20:13:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 420: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/vandetanib-shows-clinical-benefit-for-lung-cancer</loc>
		<lastmod>2010-06-08T05:12:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 419: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-smacking-seafood-for-ultimate-food-of-connoisseur</loc>
		<lastmod>2010-06-08T05:04:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 418: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/asco-mouth-cancer-patients-do-better-if-tumor-is-hpv-positive</loc>
		<lastmod>2010-06-07T14:14:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 417: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-in-your-bathroom</loc>
		<lastmod>2010-06-07T14:08:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 416: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-amg-386-data-demonstrate-promising-antitumor-activity-in-patients-with-recurrent-ovarian-cancer</loc>
		<lastmod>2010-06-06T23:09:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 415: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/know-more-about-your-lips-in-addition-to-its-requirements-requests</loc>
		<lastmod>2010-06-06T23:08:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 414: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/body-mass-index-cigarette-smoking-and-alcohol-consumption-and-cancers-of-the-oral-cavity-pharynx-and-larynx-modeling-odds-ratios-in-pooled-case-control-data</loc>
		<lastmod>2010-06-06T08:09:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 413: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/know-the-wants-your-lips</loc>
		<lastmod>2010-06-06T08:03:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 411: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/abbott-to-present-data-on-several-investigational-cancer-treatments-at-american-society-of-clinical-oncology-annual-meeting</loc>
		<lastmod>2010-06-05T17:08:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 410: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/dual-inhibition-of-pi3k-and-mtor-inhibits-autocrine-and-paracrine-proliferative-loops-in-pi3kaktmtor-addicted-lymphomas</loc>
		<lastmod>2010-06-05T02:26:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 409: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/know-more-about-your-lips-and-its-wants</loc>
		<lastmod>2010-06-05T02:25:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 408: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/act-biotech-receives-orphan-drug-designation-for-telatinib-an-orally-available-and-highly-selective-kinase-inhibitor-in-gastric-cancer</loc>
		<lastmod>2010-06-04T11:04:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 407: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/management-of-anastrozole-induced-bone-loss-in-breast-cancer-patients-with-oral-risedronate-results-from-the-arbi-prospective-clinical-trial</loc>
		<lastmod>2010-06-03T20:03:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 406: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/evaluation-of-oral-ulceration-in-primary-care</loc>
		<lastmod>2010-06-03T05:02:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 405: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/know-the-requirements-requests-your-lips</loc>
		<lastmod>2010-06-03T04:57:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 404: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/teeth-why-flossing-each-day-keeps-the-doctor-away</loc>
		<lastmod>2010-06-02T14:02:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 403: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/consult-a-san-francisco-dentist-to-detect-oral-cancer</loc>
		<lastmod>2010-06-02T13:59:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 402: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/articles-erlotinib-as-maintenance-treatment-in-advanced-non-small-cell-lung-cancer-a-multicentre-randomised-placebo-controlled-phase-3-study</loc>
		<lastmod>2010-06-01T23:00:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 401: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/marijuana-bong-hits-can-lead-to-lung-cancer</loc>
		<lastmod>2010-06-01T22:51:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 400: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/hypoxia-inducible-factor-1-expression-in-areca-quid-chewing-associated-oral-squamous-cell-carcinomas</loc>
		<lastmod>2010-06-01T07:59:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 399: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cervical-cancer-survival-rates</loc>
		<lastmod>2010-06-01T07:54:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 398: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/polymorphisms-in-cyp2a13-and-ugt1a7-genes-and-head-and-neck-cancer-susceptibility-in-north-indians</loc>
		<lastmod>2010-05-31T16:57:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 397: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/invasive-cervical-cancer-symptoms</loc>
		<lastmod>2010-05-31T16:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 396: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/amarillo-biosciences-dietary-supplement-for-dry-mouth-maxisal-launched-in-germany</loc>
		<lastmod>2010-05-31T01:58:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 395: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/promoter-hypermethylation-in-indian-primary-oral-squamous-cell-carcinoma</loc>
		<lastmod>2010-05-30T10:56:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 394: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/leptotrichia-hongkongensis-sp-nov-a-novel-leptotrichia-species-with-the-oral-cavity-as-its-natural-reservoir</loc>
		<lastmod>2010-05-29T19:54:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 393: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-effects-of-waterpipe-tobacco-smoking-on-health-outcomes-a-systematic-review</loc>
		<lastmod>2010-05-29T19:54:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 392: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/alcohol-to-blame-for-rise-in-oral-cancers</loc>
		<lastmod>2010-05-29T19:54:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 391: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/whata%c2%80%c2%99s-in-your-toothpaste</loc>
		<lastmod>2010-05-29T04:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 390: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/dasatinib-in-imatinib-resistant-or-imatinib-intolerant-chronic-myeloid-leukemia-in-blast-phase-after-2-years-of-follow-up-in-a-phase-3-study</loc>
		<lastmod>2010-05-28T13:51:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 389: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ask-the-warrior-dentist-how-can-my-dentist-spot-oral-cancer</loc>
		<lastmod>2010-05-28T13:44:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 388: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-proliferative-verrucous-leukoplakia-underdiagnosed-oral-precursor-lesion-that-requires-retrospective-clinicopathological-correlation</loc>
		<lastmod>2010-05-27T22:49:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 387: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/skin-cancer-on-cats</loc>
		<lastmod>2010-05-27T22:41:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 386: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/fda-sends-amgen-letter-regarding-vectibix-oral-statements</loc>
		<lastmod>2010-05-27T07:47:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 385: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/mesothelioma-cancer-treatment-what-to-handle-the-relatives</loc>
		<lastmod>2010-05-27T07:41:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 384: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/standard-chemo-better-than-oral-capecitabine-in-elderly-breast-cancer</loc>
		<lastmod>2010-05-26T16:53:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 383: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/quality-of-life-and-pain-determine-head-and-neck-cancers-outcome</loc>
		<lastmod>2010-05-26T16:44:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 382: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/phase-ii-trial-of-single-agent-oral-vinorelbine-in-elderly-70-years-patients-with-advanced-non-small-cell-lung-cancer-and-poor-performance-status</loc>
		<lastmod>2010-05-26T01:46:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 381: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/metastatic-bone-cancer-survival-rate</loc>
		<lastmod>2010-05-26T01:38:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 378: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-case-of-tongue-carcinoma-associated-with-chronic-graft-versus-host-disease-after-allogeneic-haematopoietic-stem-cell-transplantation</loc>
		<lastmod>2010-05-25T10:44:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 380: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/recent-advances-in-endomorphin-engineering</loc>
		<lastmod>2010-05-25T10:44:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 377: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ziopharm-to-present-further-palifosfamide-picasso-phase-ii-results-in-oral-session-at-asco</loc>
		<lastmod>2010-05-24T19:42:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 376: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/report-on-phase-ii-clinical-study-of-marshall-edwards-phenoxodiol-in-prostate-cancer-to-be-presented-at-asco</loc>
		<lastmod>2010-05-24T04:45:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 375: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/exelixis-reports-updated-phase-2-data-for-xl184-in-patients-with-recurrent-glioblastoma-to-be-presented-at-asco</loc>
		<lastmod>2010-05-23T13:41:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 374: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/esophageal-cancer-radiation-side-effects</loc>
		<lastmod>2010-05-23T13:33:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 373: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/zymogenetics-announces-upcoming-presentation-of-positive-il-21-phase-2-results-in-metastatic-melanoma-at-asco-meeting</loc>
		<lastmod>2010-05-22T22:38:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 372: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/skin-cancer-and-sun-safety-how-much-do-you-really-know</loc>
		<lastmod>2010-05-22T22:31:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 371: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/active-biotechs-tasq-prostate-cancer-project-to-be-presented-at-asco</loc>
		<lastmod>2010-05-22T07:37:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 370: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-symptoms</loc>
		<lastmod>2010-05-22T07:32:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 369: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/marshall-edwards-inc-report-on-phase-ii-clinical-study-of-marshall-edwards-phenoxodiol-in-prostate-cancer-to-be-presented-at-asco</loc>
		<lastmod>2010-05-21T16:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 368: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sinus-cancer-%e2%80%93-do-you-have-sinus-infection-or-something-more-severe</loc>
		<lastmod>2010-05-21T16:28:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 367: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/downregulation-of-ches1-and-other-novel-genes-in-oral-cancer-cells-chronically-exposed-to-areca-nut-extract</loc>
		<lastmod>2010-05-21T01:36:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 366: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/polyadp-ribose-polymerase-inhibition-frequent-durable-responses-in-brca-carrier-ovarian-cancer-correlating-with-platinum-free-interval-gynecologic-cancer</loc>
		<lastmod>2010-05-20T10:33:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 365: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/combination-therapy-with-docetaxel-and-s-1-as-a-first-line-treatment-in-patients-with-advanced-or-recurrent-gastric-cancer-a-retrospective-analysis</loc>
		<lastmod>2010-05-19T19:33:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 364: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/minimizing-the-therapy-related-morbidity-in-the-rectal-cancer-patient</loc>
		<lastmod>2010-05-19T04:31:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 363: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-%e2%80%93-a-very-painful-and-deadly-disease</loc>
		<lastmod>2010-05-19T04:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 362: Comments: 9 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/is-it-true-that-lip-gloss-causes-cancer</loc>
		<lastmod>2010-05-19T04:23:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 361: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-model-for-investigating-tobaccooral-cancer-link-developed-by-nyu-college-of-dentistry-penn-state</loc>
		<lastmod>2010-05-18T13:30:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 360: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/evolife-laboratories-reinforces-its-commitment-to-assist-oncology-nurses-at-the-ons-2010-san-diego</loc>
		<lastmod>2010-05-18T13:30:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 359: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/human-papilloma-virus-and-cancers</loc>
		<lastmod>2010-05-18T13:22:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 358: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/tasquinimod-abr-215050-a-quinoline-3-carboxamide-anti-angiogenic-agent-modulates-the-expression-of-thrombospondin-1-in-human-prostate-tumors</loc>
		<lastmod>2010-05-17T22:35:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 357: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/capecitabine-and-sixth-cranial-nerve-palsy</loc>
		<lastmod>2010-05-17T07:27:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 356: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/3-super-secrets-to-eliminating-your-upper-lip-wrinkles-naturally</loc>
		<lastmod>2010-05-17T07:21:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 355: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/actinic-lesions-in-fishermens-lower-lip-clinical-cytopathological-and-histopathologic-analysis</loc>
		<lastmod>2010-05-16T16:25:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 354: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/problems-of-lips</loc>
		<lastmod>2010-05-16T16:18:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 353: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/poniard-pharmaceuticals-announces-results-of-phase-3-spear-trial-of-picoplatin-in-small-cell-lung-cancer</loc>
		<lastmod>2010-05-16T01:24:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 352: Comments: 10 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-you-get-cancer-from-a-lip-ring-piercing</loc>
		<lastmod>2010-05-16T01:18:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 351: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-associated-fibroblasts-and-epithelial-mesenchymal-transition-in-metastatic-oral-tongue-squamous-cell-carcinoma</loc>
		<lastmod>2010-05-15T10:23:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 350: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-tips-for-you</loc>
		<lastmod>2010-05-15T10:15:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 349: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/breast-cancer-caf-oral-cyclophosphamidedoxorubicinfluorouracil</loc>
		<lastmod>2010-05-14T19:22:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 348: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/preventing-lip-wrinkles-and-lines-on-the-face</loc>
		<lastmod>2010-05-14T19:13:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 347: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/adenoid-cystic-carcinomas-of-minor-salivary-glands</loc>
		<lastmod>2010-05-14T04:20:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 346: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancer</loc>
		<lastmod>2010-05-14T04:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 345: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/concurrent-radiotherapy-and-temozolomide-followed-by-temozolomide-and-sorafenib-in-the-first-line-treatment-of-patients-with-glioblastoma-multiforme</loc>
		<lastmod>2010-05-13T13:19:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 344: Comments: 11 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/i-have-a-patch-of-dry-skin-above-my-lip-it-itches-sometimes-could-it-be-skin-cancer</loc>
		<lastmod>2010-05-13T13:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 343: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/entremed-initiates-second-site-in-enmd-2076-phase-2-ovarian-cancer-study</loc>
		<lastmod>2010-05-12T22:17:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 342: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-plumper-questions-answers</loc>
		<lastmod>2010-05-12T22:10:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 341: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/fastest-increasing-cancer-in-scotland-especially-in-men</loc>
		<lastmod>2010-05-12T07:17:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 340: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-this-brown-spot-on-my-lip</loc>
		<lastmod>2010-05-12T07:14:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 339: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/polymorphisms-of-alcohol-dehydrogenase-1b-and-aldehyde-dehydrogenase-2-and-the-blood-and-salivary-ethanol-and-acetaldehyde-concentrations-of-japanese-alcoholic-men</loc>
		<lastmod>2010-05-11T16:24:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 338: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-feasibility-of-facial-submental-artery-island-myocutaneous-flaps-for-reconstructing-defects-of-the-oral-floor-following-cancer-ablation</loc>
		<lastmod>2010-05-11T16:24:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 337: Comments: 7 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/my-mom-suspects-cancer-on-her-lip-but-refuses-to-have-it-biopsied</loc>
		<lastmod>2010-05-11T16:12:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 336: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/alternative-colon-cancer-treatments</loc>
		<lastmod>2010-05-11T16:12:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 335: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/influence-of-pathological-nodal-status-and-maximal-standardized-uptake-value-of-the-primary-tumor-and-regional-lymph-nodes-on-treatment-plans-in-patients-with-advanced-oral-cavity-squamous-cell-carcin</loc>
		<lastmod>2010-05-11T01:17:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 334: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/acantholytic-squamous-cell-carcinoma-of-the-gingiva-report-of-a-case-and-review-of-the-literature</loc>
		<lastmod>2010-05-10T10:12:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 333: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/head-and-neck-cancer-treatment-in-india-at-affordable-cost</loc>
		<lastmod>2010-05-10T10:09:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 332: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/loss-expression-of-o6-methylguanine-dna-methyltransferase-by-promoter-hypermethylation-and-its-relationship-to-betel-quid-chewing-in-oral-squamous-cell-carcinoma</loc>
		<lastmod>2010-05-09T19:11:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 331: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/laugh-out-loud-cats-1398</loc>
		<lastmod>2010-05-09T19:05:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 330: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/high-grade-oncocytic-mucoepidermoid-carcinoma-of-the-minor-salivary-gland-origin-a-case-report-with-immunohistochemical-study</loc>
		<lastmod>2010-05-09T04:09:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 329: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/interesting-acts-lip-and-oral-cavity-cancer</loc>
		<lastmod>2010-05-09T04:03:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 328: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/comparative-analysis-of-the-immunohistochemistry-expression-of-p27-p21wafcip1-and-p16ink4a-in-oral-normal-epithelium-squamous-papilloma-and-squamous-cell-carcinoma</loc>
		<lastmod>2010-05-08T13:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 327: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-mouth-cancer</loc>
		<lastmod>2010-05-08T13:00:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 326: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/comparison-of-intensity-modulated-radiotherapy-using-helical-tomotherapy-and-segmental-multileaf-collimator-based-techniques-for-nasopharyngeal-carcinoma-dosimetric-analysis-incorporating-quality-ass</loc>
		<lastmod>2010-05-07T22:07:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 325: Comments: 15 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/my-lower-lip-peels-every-day-what-can-be-the-reason-for-that-what-can-i-do-about-it-except-using-lip-balm</loc>
		<lastmod>2010-05-07T21:59:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 324: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/prognostic-utility-of-chromosomal-instability-detected-by-fluorescence-in-situ-hybridization-in-fine-needle-aspirates-from-oral-squamous-cell-carcinomas</loc>
		<lastmod>2010-05-07T07:06:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 323: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sexy-lips-qa</loc>
		<lastmod>2010-05-07T06:58:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 322: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/smokeless-tobacco-raises-oral-cancer-risk-up-to-tenfold-not-fiftyfold</loc>
		<lastmod>2010-05-06T16:04:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 321: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/causes-effects-symptoms-and-treatments-of-oral-cancer</loc>
		<lastmod>2010-05-06T15:58:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 320: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/microrna-137-promoter-methylation-in-oral-rinses-from-patients-with-squamous-cell-carcinoma-of-the-head-and-neck-is-associated-with-gender-and-body-mass-index</loc>
		<lastmod>2010-05-06T01:05:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 319: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/wilex-ag-final-phase-ii-data-of-mesupron-confirm-impressive-increase-in-overall-survival-of-patients-with-pancreatic-cancer</loc>
		<lastmod>2010-05-05T10:02:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 318: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-from-biting-inside-of-lips</loc>
		<lastmod>2010-05-05T09:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 317: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/genomics-and-proteomics-approaches-to-the-study-of-cancer-stroma-interactions</loc>
		<lastmod>2010-05-04T19:01:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 316: Comments: 9 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/does-lip-piercing-give-you-cancer</loc>
		<lastmod>2010-05-04T18:54:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 315: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/breast-cancer-survivors-may-face-second-cancers-if-they-smoke</loc>
		<lastmod>2010-05-04T03:59:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 314: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-biting-your-cheeklip-cause-cancer</loc>
		<lastmod>2010-05-04T03:51:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 313: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/parathyroid-related-protein-plays-a-critical-role-in-bone-invasion-by-oral-squamous-cell-carcinoma</loc>
		<lastmod>2010-05-03T12:58:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 312: Comments: 18 of 310 = 0.1 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/does-lip-gloss-really-cause-cancer</loc>
		<lastmod>2010-05-03T12:53:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 311: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/il-23-promotes-growth-and-proliferation-in-human-squamous-cell-carcinoma-of-the-oral-cavity</loc>
		<lastmod>2010-05-02T21:56:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 310: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/anyone-ever-experience-tumor-or-cancer-lump-on-their-dogs-upper-lip-and-throat</loc>
		<lastmod>2010-05-02T21:52:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 309: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-data-from-phase-iii-lung-cancer-trial-show-veristratr-identifies-patients-likely-to-respond-to-erlotinib</loc>
		<lastmod>2010-05-02T06:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 308: Comments: 3 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/i-have-a-huge-lump-in-my-inner-lip-is-it-cancer</loc>
		<lastmod>2010-05-02T06:56:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 307: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-role-of-targeted-agents-in-preoperative-chemoradiation-for-rectal-cancer</loc>
		<lastmod>2010-05-01T15:56:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 306: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-age-group-15-44-years-number-of-patients-observed</loc>
		<lastmod>2010-05-01T15:47:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 305: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/smoking-during-radiation-therapy-for-head-and-neck-cancers-linked-to-poorer-outcomes</loc>
		<lastmod>2010-05-01T00:53:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 304: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/causes-effects-symptoms-and-treatments-of-head-and-neck-cancer</loc>
		<lastmod>2010-05-01T00:46:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 303: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/triple-mix</loc>
		<lastmod>2010-04-30T09:52:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 302: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/makeup-for-cancer-patients-teaching-your-clients-how-to-stay-beautiful-inside-and-out</loc>
		<lastmod>2010-04-30T09:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 301: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/optical-approaches-to-oral-cancer-screening-and-diagnosis-an-expert-interview-with-petra-wilder-smith-dds-phd</loc>
		<lastmod>2010-04-29T18:52:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 300: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/colon-cancer-staging-ajcc</loc>
		<lastmod>2010-04-29T18:44:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 299: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/evaluation-of-circulating-immune-complexes-and-serum-immunoglobulins-in-oral-cancer-patients-a-follow-up-study</loc>
		<lastmod>2010-04-29T03:52:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 298: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-retrospective-clinicopathological-study-of-550-patients-with-oral-lichen-planus-in-south-eastern-spain</loc>
		<lastmod>2010-04-28T12:48:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 297: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/incidence-of-brain-metastases-in-renal-cell-carcinoma-treated-with-sorafenib</loc>
		<lastmod>2010-04-27T21:46:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 296: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-does-lip-cancer-look-like</loc>
		<lastmod>2010-04-27T21:39:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 295: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/amelioration-of-insulin-requirement-in-patients-undergoing-duodenal-bypass-for-reasons-other-than-obesity-implicates-foregut-factors-in-the-pathophysiology-of-type-ii-diabetes</loc>
		<lastmod>2010-04-27T06:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 294: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/colon-cancer-treatment-ppt</loc>
		<lastmod>2010-04-27T06:39:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 293: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-case-of-a-deeply-fissured-tongue</loc>
		<lastmod>2010-04-26T15:48:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 292: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/any-one-no-about-lip-cancer</loc>
		<lastmod>2010-04-26T15:37:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 291: Comments: 4 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-causes-lip-cancer</loc>
		<lastmod>2010-04-26T15:37:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 290: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/potentiating-effect-of-beta-glucans-on-photodynamic-therapy-of-implanted-cancer-cells-in-mice</loc>
		<lastmod>2010-04-26T00:48:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 289: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-age-group-55-64-years-number-of-patients-observed</loc>
		<lastmod>2010-04-26T00:37:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 288: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/absence-of-hotspot-mutations-in-exons-9-and-20-of-the-pik3ca-gene-in-human-oral-squamous-cell-carcinoma-in-the-greek-population</loc>
		<lastmod>2010-04-25T09:43:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 287: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-caregivers-should-never-suffer-alone</loc>
		<lastmod>2010-04-25T09:35:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 286: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/relevance-of-5-different-imaging-signs-in-the-evaluation-of-carotid-artery-invasion-by-cervical-lymphadenopathy-in-head-and-neck-squamous-cell-carcinoma</loc>
		<lastmod>2010-04-24T18:40:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 285: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/think-of-skin-cancer-when-doing-household-jobs</loc>
		<lastmod>2010-04-24T18:33:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 284: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/transport-of-a-hydrophilic-paclitaxel-derivative-7-xylosyl-10-deacetylpaclitaxel-by-human-intestinal-epithelial-caco-2-cells</loc>
		<lastmod>2010-04-24T03:47:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 283: Comments: 5 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cyst-lip-cancer-or-what</loc>
		<lastmod>2010-04-24T03:35:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 282: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/methylgene-presents-preclinical-data-for-mgcd265-a-multi-targeted-met-kinase-inhibitor-at-the-american-association-for-cancer-research-aacr-annual-meeting</loc>
		<lastmod>2010-04-23T12:37:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 281: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/skin-cancer-is-the-most-prevalent</loc>
		<lastmod>2010-04-23T12:35:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 280: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/limited-preparation-ct-colonography-in-frail-elderly-patients-a-feasibility-study</loc>
		<lastmod>2010-04-22T21:36:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 279: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/an-unsolved-mystery-is-adam-emery-really-dead</loc>
		<lastmod>2010-04-22T21:29:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 278: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/erratum-to-a%c2%80%c2%9cposter-session-iii-basic-science-epidemiology-diagnosis-radiation-injuriesa%c2%80%c2%9d-oral-oncology-supplement-3-2009-201a%c2%80%c2%93236</loc>
		<lastmod>2010-04-22T06:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 277: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/easy-ways-to-deal-with-skin-cancer-side-effects</loc>
		<lastmod>2010-04-22T06:27:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 276: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/abstracts-highlighting-sunesis-phase-2-voreloxin-data-accepted-for-presentation-at-2010-asco-meeting</loc>
		<lastmod>2010-04-21T15:54:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 275: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-skin-cancer-techniques-to-fight-with-skin-cancer</loc>
		<lastmod>2010-04-21T15:26:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 274: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/human-bone-marrow-stromal-cells-display-variable-anatomic-site-dependent-response-and-recovery-from-irradiation</loc>
		<lastmod>2010-04-21T00:32:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 273: Comments: 15 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/does-carmax-lip-balm-stuff-cause-cancer</loc>
		<lastmod>2010-04-21T00:26:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 272: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/febrile-neutropenia-in-french-emergency-departments-results-of-a-prospective-multicentre-survey</loc>
		<lastmod>2010-04-20T09:32:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 271: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancer-deaths-on-the-rise</loc>
		<lastmod>2010-04-20T09:23:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 269: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/results-of-a-surgical-resection-of-pulmonary-metastasis-from-malignant-head-and-neck-tumor-institutional-report-pulmonary</loc>
		<lastmod>2010-04-19T18:30:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 268: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-issues-men-as-caregivers</loc>
		<lastmod>2010-04-19T18:25:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 267: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/advanced-moderately-differentiated-neuroendocrine-carcinoma-of-the-rectum-with-favorable-prognosis-by-postoperative-chemoradiation</loc>
		<lastmod>2010-04-19T03:28:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 266: Comments: 7 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/which-would-be-better-to-get-pierced-your-tongue-or-lip</loc>
		<lastmod>2010-04-19T03:21:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 265: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ziopharm-commences-oral-indibulin-phase-iii-trial-in-breast-cancer</loc>
		<lastmod>2010-04-18T12:29:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 264: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/blitz-week-to-benefit-st-jude</loc>
		<lastmod>2010-04-18T12:24:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 263: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/aging-and-oral-health-effects-in-hard-and-soft-tissues</loc>
		<lastmod>2010-04-17T21:27:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 262: Comments: 11 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ok-i-use-to-dip-i-dipped-for-about-a-mouth-and-now-in-my-mouth-on-my-bottom-lip-i-have-a-dark-bump-cancer</loc>
		<lastmod>2010-04-17T21:19:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 261: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/pharmacyclics-announces-multiple-presentations-at-the-american-association-for-cancer-research-annual-meeting</loc>
		<lastmod>2010-04-17T06:27:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 260: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/facts-and-treatment-of-skin-cancer</loc>
		<lastmod>2010-04-17T06:27:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 259: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/therapeutic-efficacy-evaluation-of-curcumin-on-human-oral-squamous-cell-carcinoma-xenograft-using-multimodalities-of-molecular-imaging</loc>
		<lastmod>2010-04-16T15:22:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 258: Comments: 3 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/is-it-possible-to-get-lip-cancer</loc>
		<lastmod>2010-04-16T15:18:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 257: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/medivation-and-astellas-announce-publication-in-the-lancet-of-positive-efficacy-data-from-phase-1-2-trial-of-mdv3100-in-prostate-cancer-patiens</loc>
		<lastmod>2010-04-16T00:21:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 256: Comments: 6 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/how-long-does-it-take-to-get-lung-cancer-when-smoking-1-2-cigarettes-a-day</loc>
		<lastmod>2010-04-16T00:20:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 255: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/progestogen-treatment-options-for-early-endometrial-cancer</loc>
		<lastmod>2010-04-15T09:40:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 254: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-basal-cell-carcinoma-skin-cancer</loc>
		<lastmod>2010-04-15T09:40:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 253: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/delcaths-phase-iii-trial-data-to-be-presented-during-american-society-of-clinical-oncology-2010-annual-meeting-in-chicago</loc>
		<lastmod>2010-04-14T18:19:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 252: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-cancer-and-causes-of-cancer</loc>
		<lastmod>2010-04-14T18:12:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 251: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/treatment-of-thoracic-actinomycosis-a-retrospective-analysis-of-40-patients</loc>
		<lastmod>2010-04-14T03:19:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 250: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/mickelson%e2%80%99s-masterpiece-lefty-captures-third-green-jacket</loc>
		<lastmod>2010-04-14T03:10:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 249: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/quick-nano-bio-chip-checks-for-oral-cancer</loc>
		<lastmod>2010-04-13T12:16:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 248: Comments: 3 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bit-lower-lip-inside-while-eating-can-this-cause-cancer</loc>
		<lastmod>2010-04-13T12:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 247: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-5-aminolaevulinic-acid-ala-guided-photodynamic-diagnosis-pdd-and-treatment-of-upper-tract-transitional-cell-carcinoma-ut-tcc-a-feasibility-study</loc>
		<lastmod>2010-04-12T21:16:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 246: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-age-group-65-74-years-number-of-patients-observed</loc>
		<lastmod>2010-04-12T21:08:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 245: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ziopharm-commences-oral-indibulin-phase-iii-trial-in-breast-cancer-at-memorial-sloan-kettering-cancer-center</loc>
		<lastmod>2010-04-12T06:14:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 244: Comments: 5 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-u-get-cancer-from-a-lip-ring</loc>
		<lastmod>2010-04-12T06:07:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 243: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/most-young-adults-oral-sex-is-not-sex</loc>
		<lastmod>2010-04-11T15:14:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 242: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/skin-cancer-types-risk-factors-signs-and-treatment</loc>
		<lastmod>2010-04-11T15:08:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 241: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/aeterna-zentaris-announces-initiation-of-phase-3-registration-trial-with-perifosine-in-refractory-advanced-colorectal-cancer</loc>
		<lastmod>2010-04-11T00:11:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 240: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-age-group-65-74-years-cumulative-observed-5-year-survival</loc>
		<lastmod>2010-04-11T00:03:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 239: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/experts-update-risk-factors-and-urge-sexually-active-adults-to-get-free-screening-during-oral-head-neck-cancer-awareness-week-ohancaw</loc>
		<lastmod>2010-04-10T09:13:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 238: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/types-of-skin-cancer-how-to-prevent-skin-cancer</loc>
		<lastmod>2010-04-10T09:04:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 237: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/latest-updates-to-the-crd-databases</loc>
		<lastmod>2010-04-09T18:10:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 236: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/i-think-i-may-have-lower-lip-cancer-i-need-help</loc>
		<lastmod>2010-04-09T18:02:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 235: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/gentas-tesetaxel-granted-fast-track-designation-by-fda-for-advanced-gastric-cancer</loc>
		<lastmod>2010-04-09T03:09:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 234: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-skin-cancer-and-who-is-most-at-risk</loc>
		<lastmod>2010-04-09T03:01:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 233: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/patient-enrollment-complete-in-tragara-pharmaceuticals-phase-ii-trial-of-capoxigemr-in-non-small-cell-lung-cancer</loc>
		<lastmod>2010-04-08T12:08:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 232: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/chip-shots</loc>
		<lastmod>2010-04-08T11:59:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 231: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/fruit-and-veg-do-little-to-prevent-cancer</loc>
		<lastmod>2010-04-07T21:44:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 230: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-age-group-45-54-years-cumulative-observed-5-year-survival</loc>
		<lastmod>2010-04-07T20:58:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 229: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/keryx-receives-fda-fast-track-designation-for-krx-0401-perifosine-for-the-treatment-of-refractory-advanced-colorectal-cancer</loc>
		<lastmod>2010-04-07T06:03:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 228: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/know-your-skin-cancer</loc>
		<lastmod>2010-04-07T05:56:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 227: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/genta-initiates-confirmatory-phase-2b-trial-of-tesetaxel-in-gastric-cancer</loc>
		<lastmod>2010-04-06T15:02:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 226: Comments: 4 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/has-anyone-ever-had-a-small-lump-in-your-lower-inner-lip-and-could-it-be-cancer</loc>
		<lastmod>2010-04-06T14:55:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 225: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-research-in-womens-health-to-be-presented-in-san-francisco</loc>
		<lastmod>2010-04-06T00:01:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 224: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-squamous-cell-skin-carcinoma-skin-cancer</loc>
		<lastmod>2010-04-05T23:53:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 223: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ecological-integrity-of-streams-related-to-human-cancer-mortality-rates</loc>
		<lastmod>2010-04-05T09:01:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 222: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bevacizumab-and-osteonecrosis-of-the-jaw-incidence-and-association-with-bisphosphonate-therapy-in-three-large-prospective-trials-in-advanced-breast-cancer</loc>
		<lastmod>2010-04-04T17:58:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 221: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/information-on-skin-cancer-with-treatment</loc>
		<lastmod>2010-04-04T17:52:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 220: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/limited-mouth-opening-after-primary-therapy-of-head-and-neck-cancer</loc>
		<lastmod>2010-04-04T02:58:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 219: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/shunning-the-party-of-the-whiners</loc>
		<lastmod>2010-04-04T02:49:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 218: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/an-alternative-postoperative-pathway-reduces-length-of-hospitalisation-following-oesophagectomy-original-articles</loc>
		<lastmod>2010-04-03T11:57:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 217: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-age-group-75-99-years-cumulative-observed-5-year-survival</loc>
		<lastmod>2010-04-03T11:53:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 216: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/prognostic-value-of-the-sixth-edition-of-the-uiccs-tnm-classification-and-stage-grouping-for-oral-cancer</loc>
		<lastmod>2010-04-02T20:56:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 215: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sciclone-announces-topline-results-from-phase-2-clinical-trial-of-scv-07-for-prevention-of-oral-mucositis</loc>
		<lastmod>2010-04-02T05:53:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 214: Comments: 5 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-gloss-can-give-you-cancer</loc>
		<lastmod>2010-04-02T05:46:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 213: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/role-of-human-placental-apical-membrane-transporters-in-the-efflux-of-glyburide-rosiglitazone-and-metformin</loc>
		<lastmod>2010-04-01T14:53:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 212: Comments: 5 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/do-i-have-lip-cancer</loc>
		<lastmod>2010-04-01T14:45:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 211: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/risk-of-arterial-thromboembolic-events-with-sunitinib-and-sorafenib</loc>
		<lastmod>2010-03-31T23:50:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 210: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-coti-2-is-effective-against-aggressive-triple-negative-human-breast-cancer</loc>
		<lastmod>2010-03-31T23:50:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 209: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/do-you-have-pictures-of-early-signs-of-lip-cancer</loc>
		<lastmod>2010-03-31T23:47:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 208: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/human-papillomavirus-hpv-vaccination-and-pap-smear-results-in-adolescent-girls-a%c2%80%c2%93-have-we-seen-a-difference</loc>
		<lastmod>2010-03-31T08:51:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 207: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/from-nightmare-hospital-days-to-sweet-dreams-for-kids</loc>
		<lastmod>2010-03-31T08:51:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 206: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/enlarging-breasts-in-a-teenager</loc>
		<lastmod>2010-03-30T17:48:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 205: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/officers-grow-mustaches-for-charity</loc>
		<lastmod>2010-03-30T17:41:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 204: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/1026-robot-assisted-radical-cystectomy-with-intracorporeal-urinary-diversion-in-patients-with-bladder-cancer-oncological-and-functional-outcomes</loc>
		<lastmod>2010-03-30T02:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 203: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/defending-champ-kjeldsen-and-lawrie-share-lead-in-spain</loc>
		<lastmod>2010-03-30T02:41:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 202: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/multivariate-analysis-of-the-influence-of-patient-tumor-and-management-related-factors-on-the-outcome-of-surgical-therapy-for-facial-basal-cell-carcinoma</loc>
		<lastmod>2010-03-29T11:46:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 201: Comments: 9 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/does-lip-gloss-cause-lip-cancer</loc>
		<lastmod>2010-03-29T11:46:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 200: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/twelve-new-members-join-dfhcc</loc>
		<lastmod>2010-03-28T20:44:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 199: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/do-i-have-mouthlip-cancer</loc>
		<lastmod>2010-03-28T20:41:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 198: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/rise-in-mouth-cancer-linked-to-stis</loc>
		<lastmod>2010-03-28T05:44:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 197: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/are-you-at-risk-of-getting-cancer</loc>
		<lastmod>2010-03-28T05:35:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 196: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-sex-linked-to-rise-in-cancers</loc>
		<lastmod>2010-03-27T14:46:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 195: Comments: 8 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/possible-lip-cancer-large-sore-inside-my-lip</loc>
		<lastmod>2010-03-27T14:35:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 194: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/histone-deacetylase-inhibitor-valproic-acid-inhibits-cancer-cell-proliferation-via-down-regulation-of-the-alzheimer-amyloid-precursor-protein-cell-biology</loc>
		<lastmod>2010-03-26T23:40:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 193: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-can-you-tell-me-about-lip-and-oral-cavity-cancer</loc>
		<lastmod>2010-03-26T23:33:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 192: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/prophylactic-gastrostomy-before-chemoradiation-in-advanced-head-and-neck-cancer-a-multiprofessional-web-based-survey-to-identify-current-practice-anda%c2%a0toa%c2%a0analyse-decision-making</loc>
		<lastmod>2010-03-26T08:44:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 191: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/how-soon-is-too-soon-for-infants-to-start-drinking-soda</loc>
		<lastmod>2010-03-25T17:37:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 190: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/portola-pharmaceuticals-announces-initiation-of-phase-1-clinical-trial-of-prt062607-an-oral-syk-specific-inhibitor-for-chronic-inflammatory-disease</loc>
		<lastmod>2010-03-25T02:46:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 189: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-the-chance-of-getting-cancer-when-you-get-a-lip-piercing</loc>
		<lastmod>2010-03-25T02:46:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 188: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/occurrence-of-bisphosphonate-related-osteonecrosis-of-the-jaw-after-surgical-tooth-extraction</loc>
		<lastmod>2010-03-24T11:35:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 187: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-are-the-symptoms-of-lip-cancer</loc>
		<lastmod>2010-03-24T11:29:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 186: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/is-nevoid-basal-cell-carcinoma-syndrome-really-so-rare-proposal-for-an-investigative-protocol-based-on-a-case-series</loc>
		<lastmod>2010-03-23T20:34:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 185: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/skin-cancer-symptoms-and-signs</loc>
		<lastmod>2010-03-23T20:26:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 184: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/metastatic-renal-cell-carcinoma-to-the-oral-cavity-and-clear-cell-mucoepidermoid-carcinoma-comparative-clinicopathologic-and-immunohistochemical-study</loc>
		<lastmod>2010-03-23T05:32:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 183: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-age-group-75-99-years-number-of-patients-observed</loc>
		<lastmod>2010-03-23T05:25:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 182: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/metastases-in-odontogenic-cysts-literature-review-and-case-presentation</loc>
		<lastmod>2010-03-22T14:39:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 181: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/survivin-as-a-potential-early-marker-in-the-carcinogenesis-of-oral-submucous-fibrosis</loc>
		<lastmod>2010-03-22T14:39:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 180: Comments: 3 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/is-grizzly-more-likely-to-give-you-lip-cancer-than-skoal</loc>
		<lastmod>2010-03-22T14:23:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 179: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-case-of-primary-combined-neuroendocrine-carcinoma-with-squamous-cell-carcinoma-in-the-upper-gingiva</loc>
		<lastmod>2010-03-21T23:34:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 178: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/mareng-raya-4</loc>
		<lastmod>2010-03-21T23:34:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 177: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-delivery-of-pnd-1186-fak-inhibitor-decreases-tumor-growth-and-spontaneous-breast-to-lung-metastasis-in-pre-clinical-models</loc>
		<lastmod>2010-03-21T08:30:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 176: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/six-proven-facts-about-cancer</loc>
		<lastmod>2010-03-21T08:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 175: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/enteral-feeding-methods-for-nutritional-management-in-patients-with-head-and-neck-cancers-being-treated-with-radiotherapy-andor-chemotherapy</loc>
		<lastmod>2010-03-20T17:44:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 174: Comments: 3 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/micro-torch-self-sugery-contact</loc>
		<lastmod>2010-03-20T17:44:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 173: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/neck-restaging-with-sentinel-node-biopsy-in-t1-t2n0-oral-and-oropharyngeal-cancer-why-and-how</loc>
		<lastmod>2010-03-20T02:26:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 172: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/raising-a-heap-of-cash-for-losing-much-loved-tash</loc>
		<lastmod>2010-03-20T02:18:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 171: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/metastases-to-the-lingual-nodes-in-tongue-cancer-a-pitfall-in-a-conventional-neck-dissection</loc>
		<lastmod>2010-03-19T11:25:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 170: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sunscreens-do-they-cause-skin-cancer</loc>
		<lastmod>2010-03-19T11:17:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 169: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/vegfa-936ct-polymorphism-and-cancer-risk-a-meta-analysis</loc>
		<lastmod>2010-03-18T20:24:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 168: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/hook-n-roll</loc>
		<lastmod>2010-03-18T20:19:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 167: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sgo-hint-of-chemoprevention-potential-for-lynch-syndrome-cmece</loc>
		<lastmod>2010-03-18T05:21:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 166: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/an-article-on-cancer</loc>
		<lastmod>2010-03-18T05:14:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 165: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/narrowband-imaging-for-early-detection-of-malignant-tumors-and-radiation-effect-after-treatment-of-head-and-neck-cancer-original-article</loc>
		<lastmod>2010-03-17T14:21:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 164: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-impact-of-adjuvant-radiotherapy-on-survival-in-t1-2n1-squamous-cell-carcinoma-of-the-oral-cavity-original-article</loc>
		<lastmod>2010-03-16T23:20:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 163: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/badger-balm-%e2%80%93-the-perfect-remedy-for-dry-lips</loc>
		<lastmod>2010-03-16T23:11:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 162: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/drugging-the-pi3-kinome-from-chemical-tools-to-drugs-in-the-clinic</loc>
		<lastmod>2010-03-16T08:21:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 161: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/farmer-whitetrash-teaches-gardening-safety</loc>
		<lastmod>2010-03-16T08:21:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 160: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/women-on-pill-may-live-longer-bbc-news-online-12-march-2010</loc>
		<lastmod>2010-03-15T17:30:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 159: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/dress-code-melanie-slade-model</loc>
		<lastmod>2010-03-15T17:30:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 158: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/study-oral-contraceptives-cut-cancer-risk</loc>
		<lastmod>2010-03-15T02:16:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 157: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ed-white-port-sulphur-pep-rally-september-30-1989-part-3</loc>
		<lastmod>2010-03-15T02:08:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 156: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-efficacy-of-direct-tissue-fluorescence-visualization-in-screening-for-oral-premalignant-lesions-in-general-practice-an-update</loc>
		<lastmod>2010-03-14T11:14:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 155: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-age-group-55-64-years-cumulative-observed-5-year-survival</loc>
		<lastmod>2010-03-14T11:09:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 154: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/mucosal-melanoma-facts-and-information</loc>
		<lastmod>2010-03-13T20:13:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 153: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-age-group-15-44-years-cumulative-observed-5-year-survival</loc>
		<lastmod>2010-03-13T20:06:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 150: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/contraceptive-pill-not-associated-with-increased-long-term-risk-of-death-study-finds</loc>
		<lastmod>2010-03-13T05:31:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 149: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/diagnostic-delay-is-not-associated-with-advanced-stage-oro-pharyngeal-cancer</loc>
		<lastmod>2010-03-12T14:27:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 148: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/six-simple-steps-to-prevent-skin-cancer</loc>
		<lastmod>2010-03-12T14:10:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 147: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/induction-of-invasion-in-an-organotypic-oral-cancer-model-by-cocl2-a-hypoxia-mimetic</loc>
		<lastmod>2010-03-11T23:13:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 146: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-balm-recipe-make-your-own-natural-lip-balm-using-three-simple-ingredients</loc>
		<lastmod>2010-03-11T23:13:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 145: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/nasogastric-tube-feeding-and-percutaneous-endoscopic-gastrostomy-tube-feeding-in-patients-with-head-and-neck-cancer</loc>
		<lastmod>2010-03-11T08:08:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 144: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-sick</loc>
		<lastmod>2010-03-11T08:06:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 143: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sentinel-lymph-node-biopsy-accurately-stages-the-regional-lymph-nodes-for-t1-t2-oral-squamous-cell-carcinomas-results-of-a-prospective-multi-institutional-trial-head-and-neck-cancer</loc>
		<lastmod>2010-03-10T17:20:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 142: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancer-faqs</loc>
		<lastmod>2010-03-10T17:01:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 141: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lycopene-in-treatment-of-high-grade-gliomas-a-pilot-study</loc>
		<lastmod>2010-03-10T02:17:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 140: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-carcinoma</loc>
		<lastmod>2010-03-10T02:17:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 139: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/2010-genitourinary-canceers-symposium-merit-award-recipients</loc>
		<lastmod>2010-03-09T11:05:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 138: Comments: 4 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-dog-bit-me-in-my-lip-is-it-possible-that-i-can-get-lip-cancer</loc>
		<lastmod>2010-03-09T10:56:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 137: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/max-planck-scientists-develop-a-fingerprint-for-genes-new-strategy-to-play-major-role-in-research-on-human-diseases</loc>
		<lastmod>2010-03-08T20:04:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 136: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/get-comprehensive-oral-cancer-surgery-in-india-with-top-class-medical-care</loc>
		<lastmod>2010-03-08T19:56:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 135: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/upregulation-of-notch-pathway-molecules-in-oral-squamous-cell-carcinoma</loc>
		<lastmod>2010-03-08T05:01:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 134: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/comparative-effectiveness-trial-leads-to-evidence-based-care-for-childhood-epilepsy</loc>
		<lastmod>2010-03-08T04:53:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 133: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-study-introduces-the-prospect-for-concurrent-antiangiogenicantitumorigenic-therapy</loc>
		<lastmod>2010-03-07T14:12:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 132: Comments: 4 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-you-really-get-cancer-by-putting-lip-gloss-on</loc>
		<lastmod>2010-03-07T13:57:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 131: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/health-headlines-binge-drinking-wii-workout-games-and-cpr</loc>
		<lastmod>2010-03-06T23:04:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 130: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/covidien-launches-oral-transmucosal-fentanyl-citrate-product</loc>
		<lastmod>2010-03-06T07:59:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 129: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/things-to-look-for-with-skin-cancer</loc>
		<lastmod>2010-03-06T07:51:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 128: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/narrow-band-imaging-for-detecting-superficial-squamous-cell-carcinoma-of-the-head-and-neck-in-patients-with-esophageal-squamous-cell-carcinoma</loc>
		<lastmod>2010-03-05T16:55:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 127: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/gnc-says-thank-you-to-customers-and-employees-for-their-1-4-million-in-donations-to-the-sixth-annual-st-jude</loc>
		<lastmod>2010-03-05T16:49:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 126: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/are-smokeless-tobacco-products-safe</loc>
		<lastmod>2010-03-05T01:56:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 125: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/where-there%e2%80%99s-no-smoke</loc>
		<lastmod>2010-03-05T01:48:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 124: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/green-tea-may-be-a-cancer-fighter-cleveland-clinic-video</loc>
		<lastmod>2010-03-04T10:53:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 123: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-a-razor-cut-on-the-upper-lip-turn-into-skin-cancer</loc>
		<lastmod>2010-03-04T10:47:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 122: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/capecitabine-initially-concomitant-to-radiotherapy-then-perioperatively-administered-in-locally-advanced-rectal-cancer-in-regard-to-mg-zampino-et%c2%a0al-int-j-radiat-oncol-biol-phys-200975421-42</loc>
		<lastmod>2010-03-03T19:54:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 121: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-durring-hdrir192-interstitial-brachytherapy-at-ubon-cancer-center</loc>
		<lastmod>2010-03-03T19:44:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 120: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/uterine-specific-p53-deficiency-confers-premature-uterine-senescence-and-promotes-preterm-birth-in-mice</loc>
		<lastmod>2010-03-03T04:50:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 119: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/area-firefighters-grow-whiskers-for-a-cause</loc>
		<lastmod>2010-03-03T04:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 118: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/celecoxib-enhances-the-inhibitory-effect-of-cisplatin-on-tca8113-cells-in-human-tongue-squamous-cell-carcinoma-in-vivo-and-in-vitro</loc>
		<lastmod>2010-03-02T13:50:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 117: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-self-surgery-on-disabled-vets-lip-with-dry-ice</loc>
		<lastmod>2010-03-02T13:42:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 116: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ultrasensitive-electrochemical-immunosensor-for-oral-cancer-biomarker-il-6-using-carbon-nanotube-forest-electrodes-and-multilabel-amplification</loc>
		<lastmod>2010-03-01T22:48:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 115: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/skin-cancer-information-early-signs-and-types-of-skin-cancer</loc>
		<lastmod>2010-03-01T22:42:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 114: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/genta-initiates-once-weekly-treatment-schedule-for-tesetaxel-a-novel-oral-tubulin-inhibitor-in-new-dose-ranging-study</loc>
		<lastmod>2010-03-01T07:48:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 113: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/poor-and-inconsistent-reimbursement-of-oral-cancer-drugs-impairs-treatment</loc>
		<lastmod>2010-02-28T16:47:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 112: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/effective-homemade-remedies-for-skin-cancer</loc>
		<lastmod>2010-02-28T16:47:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 111: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/massive-hematuria-from-the-bilateral-upper-urinary-tract-in-a-patient-treated-for-advanced-lung-cancer-with-gefitinib</loc>
		<lastmod>2010-02-28T01:45:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 110: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/chapped-lips-treatment-%e2%80%93-get-your-lips-more-beautiful</loc>
		<lastmod>2010-02-28T01:37:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 109: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/the-aktpkb-family-of-protein-kinases-a-review-of-small-molecule-inhibitors-and-progress-towards-target-validation-a-2009-update</loc>
		<lastmod>2010-02-27T10:45:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 108: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/any-hope-for-a-cure</loc>
		<lastmod>2010-02-27T10:35:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 107: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-medicines-profile-fentanyl-nasal-spray-instanyl%c2%ae</loc>
		<lastmod>2010-02-26T19:41:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 106: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/skin-cancer-prevention-how-can-i-live-an-active-lifestyle-and-still-protect-myself-from-skin-cancer</loc>
		<lastmod>2010-02-26T19:34:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 105: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/heal-yourself-in-15-days-by-cleaning-up-your-skin-exposure-part-ten</loc>
		<lastmod>2010-02-26T04:48:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 104: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ghana-to-host-second-who-meeting-on-tobacco</loc>
		<lastmod>2010-02-26T04:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 103: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sibling-proteins-may-predict-oral-cancer</loc>
		<lastmod>2010-02-25T13:51:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 102: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/11-cancer-self-surgery-on-disabled-vets-lip-with-dry-ice-11-of-15</loc>
		<lastmod>2010-02-25T13:51:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 101: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancer-study-shows-full-tumor-genome-novel-method-speeds-analysis-for-individualized-medicine</loc>
		<lastmod>2010-02-24T22:44:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 100: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/5-cancer-self-surgery-on-disabled-vets-lip-with-dry-ice-5-of-15</loc>
		<lastmod>2010-02-24T22:44:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 99: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/characteristics-of-head-and-neck-cancer-patients-referred-to-an-oral-and-maxillofacial-surgeon-in-the-united-states-for-management</loc>
		<lastmod>2010-02-24T07:37:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 98: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/andy-gump-and-his-deformity</loc>
		<lastmod>2010-02-24T07:37:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 97: Comments: 3 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/is-it-a-wart-or-lip-cancer</loc>
		<lastmod>2010-02-24T07:28:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 96: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancers-toll-especially-cruel</loc>
		<lastmod>2010-02-23T16:39:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 95: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/velscope-system-being-used-to-screen-winter-olympic-athletes-for-oral-cancer</loc>
		<lastmod>2010-02-23T16:32:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 94: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/effect-of-troglitazone-on-tumor-growth-and-pulmonary-metastasis-development-of-the-mouse-osteosarcoma-cell-line-lm8</loc>
		<lastmod>2010-02-23T01:35:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 93: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/vulvar-cancer-%e2%80%93-information-on-vulvar-cancer</loc>
		<lastmod>2010-02-23T01:26:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 92: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancers-toll-can-be-cruel</loc>
		<lastmod>2010-02-22T10:37:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 91: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/how-much-does-getting-my-bottom-lip-pierced-compared-to-the-cervical-cancer-needle</loc>
		<lastmod>2010-02-22T10:28:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 90: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/study-poor-and-inconsistent-reimbursement-of-oral-cancer-drugs-impairs-treatment</loc>
		<lastmod>2010-02-21T19:37:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 89: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/4-cancer-self-surgery-on-disabled-vets-lip-with-dry-ice-4-of-15</loc>
		<lastmod>2010-02-21T19:37:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 88: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/when-to-address-level-i-lymph-nodes-in-neck-dissections</loc>
		<lastmod>2010-02-21T04:30:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 87: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/outcomes-of-laser-thermal-therapy-for-recurrent-head-and-neck-cancer</loc>
		<lastmod>2010-02-21T04:30:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 86: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/my-secret-to-surviving-cancer</loc>
		<lastmod>2010-02-21T04:25:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 85: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/super-sensitive-cancer-blood-tests-within-five-years</loc>
		<lastmod>2010-02-20T13:35:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 84: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancer-causes-symptoms-and-treatments</loc>
		<lastmod>2010-02-20T13:35:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 83: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/neo-adjuvant-chemo-radiation-of-rectal-cancer-with-volumetric-modulated-arc-therapy-summary-of-technical-and-dosimetric-features-and-early-clinical-experience</loc>
		<lastmod>2010-02-19T22:30:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 82: Comments: 4 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-the-first-sign-of-lip-cancer</loc>
		<lastmod>2010-02-19T22:19:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 81: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/identification-of-increased-nbs1-expression-as-a-prognostic-marker-of-squamous-cell-carcinoma-of-the-oral-cavity</loc>
		<lastmod>2010-02-19T07:36:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 80: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/nba-injury-report</loc>
		<lastmod>2010-02-19T07:36:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 79: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/safe-practice-and-nursing-care-of-patients-receiving-oral-anticancer-medicines</loc>
		<lastmod>2010-02-18T16:25:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 78: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/information-on-lip-and-oral-cavity-cancer</loc>
		<lastmod>2010-02-18T16:19:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 77: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/biomodels-oral-mucositis-expertise-speeds-up-fda-approval-for-actogenixs-phase-1b-trial-of-ago13-in-cancer-patients</loc>
		<lastmod>2010-02-18T01:26:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 76: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/could-lip-gloss-increase-your-cancer-risk</loc>
		<lastmod>2010-02-18T01:20:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 75: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/hopes-for-kidney-cancer-treatment</loc>
		<lastmod>2010-02-17T10:25:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 74: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/decrease-of-ultraviolet-a-light%e2%80%93induced-%e2%80%9ccommon-deletion%e2%80%9d-in-healthy-volunteers-after-oral-polypodium-leucotomos-extract-supplement-in-a-randomized-clinical-trial</loc>
		<lastmod>2010-02-16T19:21:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 73: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/what-is-the-scienctific-name-of-lip-cancer</loc>
		<lastmod>2010-02-16T19:13:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 72: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/incidence-of-malignancy-in-primary-sjogrens-syndrome-in-a-chinese-cohort</loc>
		<lastmod>2010-02-16T04:19:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 71: Comments: 3 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/6-cancer-self-surgery-on-disabled-vets-lip-with-dry-ice-6-of-15</loc>
		<lastmod>2010-02-16T04:14:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 70: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/glaxosmithkline-introduces-cares-by-gsk-to-improve-patient-access-to-gsk-oncology-and-specialty-medicines</loc>
		<lastmod>2010-02-15T13:19:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 69: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/fight-against-lip-cancer-keychain</loc>
		<lastmod>2010-02-15T13:13:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 68: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bone-pain-reduction-in-patients-with-metastatic-breast-cancer-treated-with-ibandronate%e2%80%93results-from-a-post-marketing-surveillance-study</loc>
		<lastmod>2010-02-14T22:21:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 67: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/why-oral-cancer-screening-is-detrimental-to-your-wellbeing</loc>
		<lastmod>2010-02-14T22:11:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 66: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/fda-encourages-patients-to-record-their-exposure-to-medical-radiation</loc>
		<lastmod>2010-02-14T07:17:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 65: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/micro-torch-self-surgery-fail-on-lip-cancer</loc>
		<lastmod>2010-02-14T07:09:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 64: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/incidence-of-oral-cancer-in-relation-to-nickel-and-arsenic-concentrations-in-farm-soils-of-patients-residential-areas-in-taiwan</loc>
		<lastmod>2010-02-13T16:14:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 63: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/frisbee-inventor-dies-at-90</loc>
		<lastmod>2010-02-13T16:06:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 62: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/4sc-announces-treatment-of-first-patient-in-a-phase-i-study-of-4sc-205</loc>
		<lastmod>2010-02-13T01:14:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 61: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/frisbee-creator-dies</loc>
		<lastmod>2010-02-13T01:05:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 60: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/late-onset-hepatic-veno-occlusive-disease-post-autologous-peripheral-stem-cell-transplantation-successfully-treated-with-oral-defibrotide</loc>
		<lastmod>2010-02-12T10:16:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 59: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-screen-cool-mint</loc>
		<lastmod>2010-02-12T10:05:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 58: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/role-of-nitric-oxide-and-antioxidant-enzymes-in-the-pathogenesis-of-oral-cancer</loc>
		<lastmod>2010-02-11T19:13:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 57: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-for-the-fool-niggaa</loc>
		<lastmod>2010-02-11T19:09:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 56: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/dana-farber-cancer-institute-news-tips-for-february-2010</loc>
		<lastmod>2010-02-11T04:11:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 55: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancer-and-vizilite</loc>
		<lastmod>2010-02-11T04:11:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 54: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/health-news-of-the-day</loc>
		<lastmod>2010-02-10T13:21:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 53: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/beating-lip-cancer-together-keychain</loc>
		<lastmod>2010-02-10T13:21:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 52: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sentinel-nodes-predict-spread-in-oral-cancer-cmece</loc>
		<lastmod>2010-02-09T22:06:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 51: Comments: 22 of 310 = 0.1 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/i-keep-getting-a-sore-on-my-lip-could-it-be-cancer</loc>
		<lastmod>2010-02-09T22:06:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 50: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/phase-ii-study-of-oral-fingolimod-fty720-in-multiple-sclerosis-3-year-results</loc>
		<lastmod>2010-02-09T07:19:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 49: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-gloss-use-linked-to-cancer</loc>
		<lastmod>2010-02-09T07:00:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 48: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/progenics-presents-novel-multiplex-pi3-kinase-inhibitors-at-american-association-for-cancer-research-conference-on-protein-translation-and-cancer</loc>
		<lastmod>2010-02-08T16:04:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 47: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cure-lip-cancer-mug</loc>
		<lastmod>2010-02-08T16:04:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 46: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-case-of-gouty-arthritis-following-percutaneous-radiofrequency-ablation-for-hepatocellular-carcinoma</loc>
		<lastmod>2010-02-08T01:22:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 45: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/solder-iron-self-surgery-lip-cancer</loc>
		<lastmod>2010-02-08T01:22:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 44: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/sexual-behaviours-and-the-risk-of-head-and-neck-cancers-a-pooled-analysis-in-the-international-head-and-neck-cancer-epidemiology-inhance-consortium</loc>
		<lastmod>2010-02-07T10:07:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 43: Comments: 2 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/if-you-bite-your-lips-does-that-increase-lip-cancer</loc>
		<lastmod>2010-02-07T09:55:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 42: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-therapy-slows-progression-of-advanced-kidney-cancer</loc>
		<lastmod>2010-02-06T19:11:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 41: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cancer-free-third-edition</loc>
		<lastmod>2010-02-06T19:11:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 40: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/heal-yourself-in-15-days-with-the-health-rangers-living-juice-recipe-part-five</loc>
		<lastmod>2010-02-06T04:06:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 39: Comments: 4 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/ive-had-my-lip-pierced-for-6-months-can-dip-get-in-it-and-cause-lip-cancer</loc>
		<lastmod>2010-02-06T04:06:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 38: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-fingolimod-or-intramuscular-interferon-for-relapsing-multiple-sclerosis</loc>
		<lastmod>2010-02-05T13:02:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 37: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/beating-lip-cancer-together-mug</loc>
		<lastmod>2010-02-05T13:02:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 36: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/world-cancer-day-2010</loc>
		<lastmod>2010-02-04T22:00:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 35: Comments: 6 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-you-get-lip-cancer-from-biting-the-skin-inside-of-your-cheeks-and-lips-until-it-bleeds</loc>
		<lastmod>2010-02-04T22:00:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 34: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/minichromosome-maintenance-7-and-geminin-are-reliable-prognostic-markers-in-patients-with-oral-squamous-cell-carcinoma-immunohistochemical-study</loc>
		<lastmod>2010-02-04T07:13:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 33: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/cure-lip-cancer-keychain</loc>
		<lastmod>2010-02-04T07:13:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 32: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/gsks-tykerbr-receives-accelerated-approval-for-first-line-combination-treatment-of-metastatic-breast-cancer</loc>
		<lastmod>2010-02-03T15:55:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 31: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/avseq06-healing-of-lip-cancer-by-jesus-christ-dat</loc>
		<lastmod>2010-02-03T15:55:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 30: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/new-campaign-focuses-on-unseen-harms-of-alcohol</loc>
		<lastmod>2010-02-03T00:53:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 29: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/low-cost-mouth-and-throat-cancer-surgery-in-india-along-with-medical-tourism-and-healthcare-facilities</loc>
		<lastmod>2010-02-03T00:53:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 28: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/bone-marrow-transplant-still-useful-in-leukaemia</loc>
		<lastmod>2010-02-02T09:58:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 27: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/reflection-and-reaction-targeting-the-target-a-step-forward-for-the-treatment-of-non-small-cell-lung-cancer</loc>
		<lastmod>2010-02-02T09:58:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 26: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-screen-almond</loc>
		<lastmod>2010-02-02T09:45:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 25: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/treatment-of-cancer-with-oral-drugs-a-position-statement-by-the-spanish-society-of-medical-oncology-seom</loc>
		<lastmod>2010-02-01T18:58:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 24: Comments: 12 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/did-you-know-lip-gloss-can-cause-lip-cancer</loc>
		<lastmod>2010-02-01T18:58:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 23: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/keryx-biopharmaceuticals-announces-positive-phase-2-study-results-of-perifosine-as-a-single-agent-for-the-treatment-of-waldenstroms-macroglobulinemia</loc>
		<lastmod>2010-02-01T04:53:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 22: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancer-%e2%80%93-what-is-oral-cancer</loc>
		<lastmod>2010-02-01T04:53:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 21: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-session-ii-a-oii-adrug-metabolismpharmacogentics-and-breast-cancer-therapeutics430-pm-530-pm</loc>
		<lastmod>2010-01-31T13:06:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 20: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/fight-against-lip-cancer-mug</loc>
		<lastmod>2010-01-31T13:06:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 19: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/hepatic-protection-effect-of-the-alcoholic-extract-from-camellia-sinensis-l-kuntze-green-tea-in-wistar-rats-treated-with-diethylnitrosamine</loc>
		<lastmod>2010-01-30T22:52:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 18: Comments: 3 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/how-can-i-lower-the-chances-of-getting-lip-cancer-and-still-use-dip</loc>
		<lastmod>2010-01-30T22:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 17: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/wakefield-was-dishonest-and-irresponsible-over-mmr-research-says-gmc</loc>
		<lastmod>2010-01-30T07:25:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 16: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer-surgery-3d-medical-animation-on-dr-oz</loc>
		<lastmod>2010-01-30T07:25:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 15: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/inhibition-of-bladder-cancer-development-by-allyl-isothiocyanate</loc>
		<lastmod>2010-01-29T15:48:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 14: Comments: 9 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-you-get-a-lip-cancer-from-smoking-cigarettes</loc>
		<lastmod>2010-01-29T15:48:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 13: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/a-visit-to-your-dentist-may-save-your-life</loc>
		<lastmod>2010-01-29T01:08:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 12: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/oral-cancer-prevention-detection</loc>
		<lastmod>2010-01-29T01:08:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/targeted-oral-drug-pazopanib-slows-progression-of-advanced-kidney-cancer</loc>
		<lastmod>2010-01-28T09:51:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10: Comments: 17 of 310 = 0.1 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/can-you-really-get-lip-cancer-from-lipsticks</loc>
		<lastmod>2010-01-28T09:51:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/pleural-mesothelioma-phase-iii-clinical-trial-will-continue</loc>
		<lastmod>2010-01-27T18:40:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/lip-cancer</loc>
		<lastmod>2010-01-27T18:35:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7: Comments: 0 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/mouth-cancer-i-lost-half-my-tongue-in-fight-with-tumour</loc>
		<lastmod>2010-01-27T03:38:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6: Comments: 1 of 310 = 0 points -->
	<url>
		<loc>http://lipcancer.eu/treatment/14-cancer-self-surgery-on-disabled-vets-lip-with-dry-ice-14-of-15</loc>
		<lastmod>2010-01-27T03:31:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://lipcancer.eu/contact</loc>
		<lastmod>2010-01-27T03:19:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://lipcancer.eu/privacy-policy</loc>
		<lastmod>2010-01-27T03:18:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: End Postings -->
<!-- Debug: Start Custom Pages -->
<!-- Debug: End Custom Pages -->
<!-- Debug: Start additional URLs -->
<!-- Debug: End additional URLs -->
</urlset>